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GENERAL INTRODUCTION 
Objectives of Dissertation Research 
In 1987, a new disease syndrome in pigs was recognized as causing both respiratory 
disease and reproductive failure in United States swine herds (Hill, 1990). The causative 
agent, porcine reproductive and respiratory syndrome virus (PRRSV), was first isolated in 
the Netherlands in 1991 on primary porcine alveolar macrophages (PAMs) and was 
designated Lelystad virus (LV) (Wensvoort et al., 1991). The first PRRSV in the United 
States was isolated shortly after that on a continuous cell line (Collins et al., 1992; Kim et 
ai., 1993; Meng et al., 1996a). The virus spread rapidly and is now found throughout 
Europe, North America, and Asia (Chueh et al., 1998; Lindhaus and Lindhaus, 1991; 
Murakami et al., 1994; Paton et al., 1991; Plana et al., 1992). In 1991, seroprevalence of 
PRRSV was estimated to be as high as 60-80% in U.S. herds (Zimmerman et al., 1997). 
Comparisons of the European and U.S. PRRSV strains show that they are 
structurally and antigenically related, but represent genetically distinct groups (Meng et al., 
1995a; Nelson et al., 1999; Wensvoort et al., 1992). Differences have been demonstrated in 
both reproductive and respiratory pathogenicity among U.S. PRRSV isolates and in 
comparison to isolates from Europe (Halbur et al., 1996; Halbur et al., 1995; Mengeling et 
al., 1996; Park et al., 1996). These differences have been attnbuted to a complex of factors 
including those associated with environment, host susceptibility, and virus strain 
differences. Genetic differences among isolates of varying pathogenicities have been well 
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established, but the regions of the genome responsible for these differences in virulence are 
unknown (Goyal, 1993; Halbur et al., 1995; Meng et al., 1995b; Meng et al., 1996b). 
The overall objective of this dissertation was to establish a model of high and low 
virulence strains firom the same lineage. Since there is substantial nucleotide diversity 
among North American PRRSV strains, it has been difRcult to correlate changes in specific 
regions of the genome with changes in pathogenicity (Andreyev et al., 1997; Kapur et al., 
1996; Meng et al., 1995b; Murtaugh et al., 1998). In this study, the strain to strain genetic 
variations are removed by using two passages from the same original virus isolate. The 
overall hypothesis of this research was that serial passage of PRRSV isolate VR-2385 in a 
continuous cell line, CRLl 1171, would result in genetic and phenotypic changes that lead 
to a decrease in virulence. The specific aims for validating this hypothesis were; 
(1) Determine if serial cell culture passage resulted in a decrease in virulence by observing 
the clinical and pathological signs resulting from experimental infection with VR-2385 
passage 8 (p8) and passage 85 (p85) in nursery pigs; (2) Determine the genome sequence 
of VR-2385 p85 and compare it to the sequence of the parent isolate; (3) Determine the 
effect of serial passage of VR-2385 on virus growth in a continuous cell line and primary 
cells. 
The initial objective was to compare the lithogenicity of VR-2385 p8 and p85. 
After VR-2385 p8 and p85 were found to significantly differ in their ability to cause 
respiratory disease in young pigs, these strains were examined for a genetic and/or biologic 
correlate of virulence. The sequence of VR-2385 p85 was determined to differ from the 
parent strain by less than 1% at the nucleotide level and regions potentially important for 
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virulence were identified. Once these objectives were met, the next goal was to identify a 
biological characteristic or marker that could be used to differentiate isolates of different 
pathogenicity. Prior to doing this, PRRSV replication in cell culture was examined and 
optimized. The replication ability of the two passages of VR-238S was then examined in a 
continuous cell line and primary cells to determine if in vitro growth characteristics 
correlated with the in vivo differences in virulence. 
Dissertation Organization 
This dissertation begins with a general introduction. A literature review relevant to 
this dissertation precedes the first manuscript There are three separate manuscripts 
contained in this dissertation, each prepared according to the guidelines of the journal to 
which it has or will be submitted. The Ph.D. candidate, Susan Schommer, is the primary 
author for all three manuscripts. The first manuscript, "Comparison of porcine 
reproductive and respiratory syndrome virus (PRRSV) growth in fetal bovine serum and a 
serum replacement supplemented media" has been submitted to the Journal of Veterinaiy 
Diagnostic Investigation and describes the findings firom the optimization of PRRSV 
growth in cell culture. All of the work included in this paper was completed by the PhD. 
candidate. The second manuscript, 'Torcine reproductive and respiratory syndrome virus 
genome changes during cell culture attenuation" will be submitted to the journal Archives 
of Virology. Sequencing of the VR-238S p85 genome was completed by the primary 
author, Susan Schommer, while sequencing of VR-2385 p7 was previously performed by 
Drs. Igor Morozov and Xiang-Jin Meng. The third manuscript, '^ Biological characterization 
4 
of a cell culture-attenuated porcine reproductive and respiratory syndrome virus (PRRSV) 
isolate" will be submitted to the journal Virus Research and discusses the in vivo and in 
vitro growth characteristics of the two passages of VR-2385. For this study, gross and 
pathologic examination of tissues was performed by Dr. Patrick Halbur and clinical disease 
was monitored by Ryan Royer. The Ph.D. candidate assisted with animal care and 
monitoring, as well as completed all of the cell culture work including inoculum 
preparation. The three manuscripts are followed by general conclusions and the references 
for the general introduction, literature review and general conclusions. 
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LITERATURE REVIEW 
History and Etiology of PRRS 
A new disease syndrome in pigs was first recognized in the United States in 1987, 
characterized as causing both respiratory disease and reproductive failure in swine herds 
(Hill, 1990). Im'tially this syndrome was known as mystery swine disease, since the 
causative agent was unknown (Hill, 1990; Keffaber, 1989). In late 1990, a similar disease 
was reported in Germany and the Netherlands (Wensvoort et al., 1991). Since then, this 
syndrome has been reported throughout North America, Europe, and Asia including 
Canada, Germany, Spain, the United Kingdom, Czechoslovakia, Denmark, Taiwan, Japan, 
and Korea (Lindhaus and Lindhaus, 1991; Murakami et al., 1994; Paton et al., 1991; Plana 
et al., 1992; VaJicek et al., 1997). This syndrome was referred to by various names 
throughout the world including swine infertility syndrome (SIRS) (Collins, 1991), mystery 
swine disease (MSD), blue ear disease (White, 1991), Heko-Heko and porcine epidemic 
abortion and respiratory syndrome (PEARS) (Meredith, 1992; Pol et al., 1991; Wensvoort, 
1993). It was agreed to adopt the name porcine reproductive and respiratory disease 
syndrome (PRRS) in 1992 at the first international meeting on this disease (Collins, 1993). 
In 1991, the agent causing this disease was found to be a virus and was isolated on 
primary swine alveolar macrophages at the Central Veterinary Institute at Lelystad, the 
Netherlands (Pol et al., 1991; Wensvoort et al., 1991). This first European PRRS virus 
(PRRSV) isolate, designated Lelystad virus (LV) was shown to cause PRRS in 
experimentally infected pigs and fiilfilled Koch's postulates (Pol et al., 1991; Terpstra et 
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al., 1991; Wensvoort et al., 1991). PRRSV was isolated in the United States in 1992 using 
a continuous cell line, ATCC CL2621, and was demonstrated to be the causative agent of 
PRRSV in the U.S. (Benfield et al., 1992; Collins et al., 1992). Since this time many other 
PRRSV isolates have been reported, and several other cell lines have been shown to 
support PRRSV replication including a subpopulation of MA-104 cells known as MARC 
145 and the ATCC CRLl 1171 cell line (Kim et al., 1993; Meng et al., 1996a). PRRSV also 
replicates in primary swine alveolar macrophages and at least one European strain is able to 
grow in the swine testes (ST) cell line (Plana et al., 1992; Wensvoort et al., 1991). The 
Lelystad virus (LV) and U.S. isolates, collectively known as PRRSV, have been shown to 
be antigem'cally and genetically related, but represent two distinct members of a common 
family that can be readily differentiated by polyclonal and monoclonal antibodies, in situ 
hybridization (ISH), and the polymerase chain reaction (PCR) (Gagnon and £)ea, 1998; 
Gilbert et al., 1997; Larochelle and Magar, 1997; Mardassi et al., 1994; Nelson et al., 1993; 
Oleksiewicz et al., 1998a; Wensvoort et al., 1992). Due to the substantial variation 
throughout the genome, it has been proposed that the European and U.S. PRRSV evolved 
independently on separate continents, though they may share a common ancestor 
(Murtaugh et al., 1995; Nelsen et al., 1999). 
Biologic and Physical Characteristics 
PRRSV is a small virus with a single positive-strand RNA genome. Infectivity of 
PRRSV is completely lost when pretreated with chloroform, suggesting the presence of a 
h'pid envelope (Benfield etal., 1992; Meng etal., 1996a; Wensvoort et al., 1991). An 
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electron-translucent ring surrounding virus particles was also observed during electron 
microscopy, further indicating the presence of a lipid envelope (Beofield et al., 1992; Meng 
et al., 1996a). Virus particles were observed to be predominantly spherical and to have a 
diameter of48-84 nm, with a nucleocapsid core of20-35 nm (Benfield et al., 1992; Meng 
et al., 1996a; Wensvoort et al., 1991). Buoyant density of the PRRS virus was found to be 
1.18-1.19 g/ml using a cesium chloride gradient (Benfield et al., 1992; Meng et al., 1996a; 
Wensvoort et al., 1991). The PRRSV was inactivated after 48 hours of incubation at 37 "C 
and 45 minutes at 56 'C, but infectivity was unchanged after 1 month at 4 "C and 4 months 
at -70 ®C (Benfield et al., 1992). Viral infectivity was also affected by pH, and it dropped 
by 90% at a pH less than 5 or greater than 7 (Benfield et al., 1992). The virus was found to 
be nonhemagglutinating after testing with erythrocytes of several animal species (Benfield 
et al., 1992; Meng et al., 1996a; Wensvoort et al., 1991; Yoon et al., 1992b). 
Cytopathic effect (CPE) caused by the virus in continuous cell lines has been 
described by degeneration of cells, cell rounding and clumping of cells, eventually leading 
to complete destruction of the monolayer (Benfield et al., 1992; Meng et al., 1996a). The 
small round clumps of cells appear to be raised above the monolayer and are found 
regardless of the cell line used (Benfield et al., 1992; Kim et al., 1993; Meng et al., 1996a). 
The tropism of PRRSV has been shown to be extremely limited, after testing more 
than 30 cell lines only continuous cell lines derived &om MA-104 cells were able to 
support productive infections (Menget al., 1996a; Wensvoort et al., 1991; Yoon et al., 
1992b). Cell lines tested included others derived from monkey tissues as well as primary 
cells and continuous cell lines from pig tissue (Meng et al., 1996a). A study done on 
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PRRSV tropism found that Vero cells, another monkey kidney cell line, were able to bind 
and internalize U.S. prototype strain VR-2332 but could not replicate the virus (Kreutz, 
1998). In the same study, PRRSV was unable to bind ST cells and could not replicate in 
this cell type even when the cells were transfected with viral RNA (Kreutz, 1998). This 
contrasted the previous finding that one European PRRSV isolate was able to infect and 
propagate in ST cells (Plana et al., 1992). This difference in ability to replicate in ST cells 
may be associated with the substantial difference in sequence between the European and 
U.S. PRRSV genotypes. Many U.S. PRRSV isolates have been found to replicate in either 
PAMs or a continuous cell line but not both, further suggesting there may be differences in 
receptor binding or replication mecham'sms among isolates (Bautista et al., 1993b). Even 
in the primary cell type that PRRSV infects in the host, PAMs, there is only a subset of 
susceptible cells (Duan et al., 1997). Recent observations suggest that PRRSV enters cells 
via receptor-mediated endocytosis and the specificity of the receptor probably plays a role 
in the limited tropism (Duan et al., 1998; Duan et al., 1997; Kreutz, 1998). There must be 
other cell factors involved since not all cell types transfected with PRRSV RNA were able 
to replicate the virus (Kreutz, 1998). 
Classification 
Originally, PRRSV was grouped as a member of the Togaviridae based on virion 
size, genome size and its icosahedral nucleocapsid, but its lack of cross-reactivity with 
other members of the group led to the proposal that it was a member of a new genera 
(Benfield et al., 1992; Plagemann and Moennig, 1992). At the X*'' International Congress 
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of Virology in Jerusalem, a new order of viruses was created, known as Nidovirales, so 
named because nidus means nest in Latin and all members form a 3' co-terminal nested set 
of subgenomic RNAs (Cavanagh, 1997). This order was comprised of two families, the 
Coronaviridae and the Arteriviridae, with PRRSV as a member of the genus Arterivirus, 
within the latter family. All members of the order Nidovirales have linear, non-segmented, 
positive single-strand polyadenylated RNA genomes, with the Arteriviruses having a much 
smaller genome than the Coronaviruses. The viruses in this order also share similar 
genome organization, with the genomic RNA functioning as the messenger RNA (mRNA) 
and the S' gene product, the replicase, is directly translated. 
Members of the Arteriviridae are different morphologically from the 
Coronaviridae with a lack of the prominent surface proteins characteristic of coronaviruses 
and an observable isometric nucleocapsid as opposed to the helical nucleocapsid of 
coronaviruses. Arteriviruses also share a tropism for cells of the macrophage lineage and 
are capable of producing subclinical and/or persistent infections (Plagemann and Moennig, 
1992). There is no antibody cross-reaction among the members of the Arteriviridae, which 
includes lactate dehydrogenase-elevating virus (LDV), equine arteritis virus (EAV), and 
simian hemorrhagic fever virus (SHFV) (Benfield et al., 1992; Chen and Plagemann, 1995; 
Kefifaber, 1989). However, degenerate primers have been designed to amplify all of the 
different family members (Benfield et al., 1992; Chen and Plagemann, 1993; Keffaber, 
1989). European and North American PRRSV isolates are genetically distant with only 
about 60% nucleotide identity, which is similar to PRRSV relatedness to LDV, while EAV 
and SHFV are more distantly related (Meng et al., 1995a; Murtaugh et al., 1995). There are 
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indications that a common ancestor may have preceded the currently identified 
Arteriviruses (Meng et al., 1995a). 
Genome Organization and Replication 
PRRSV has a polyadenylated, positive-strand RNA genome of about 15 kb with an 
organization and replication mechanism characteristic of its family Nidoviridae (Figure 1) 
(Cavanagh, 1997). It had been generally accepted that there were 8 open reading frames 
(ORFs) in the PRRSV genome, but recently a ninth ORF of unknown significance was 
described (Conzehnann et al., 1993; Meulenberg et al., 1993a; Snijder et al., 1999). In 
LV, each of the ORFs overlap each other from just a 1 base overlap of ORFs 4 and 5 to a 
253 base overlap between ORFs 3 and 4 (Conzelmann et al., 1993; Meulenberg et al., 
1993a). For the U.S. PRRSV isolates, there is no overlap between ORFs 4 and 5, instead 
there is a 10 base non-coding region, while the remaining ORFs overlap (Meng et al., 
1995b; Morozov et al., 1995). At the 5' end of the genome there is a region known as the 
leader sequence. This sequence is also located on the 5' end of every subgenomic mRNA 
(sgmRNA) produced by the PRRSV. ORFs la and lb make up 80% of the viral genome 
and are believed to code for the replicase gene (Meulenberg et al., 1993a). ORF la is 
translated directly from the genomic RNA (gRNA), but a -1 translational frameshifl is 
required for ORF lb expression. The genome sequence contains both a slippery sequence 
and a downstream pseudoknot characteristic of a frameshift motif ORF lb is then 
expressed as part of the polyprotein ORF lab. Recently, four host proteins were reported to 
bind the negative strand RNA of SHFV at the 3' end, which is the leader sequence 
complement (Hwang and Brinton, 1998). These proteins could also interact with the same 
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PRRSV genome organization 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 KB 
S'i 
la 
lb 
2b 
0 a AAA 3' ORFs 
Genomic RNA 
AAA 
subgenomic RNAs 
i  A A A  2  
I AAA 3 
I AAA 4 
1  A A A  5  
1 A A A  6  
LAAA 7 
Figure 1. Genome organization and subgenomic messenger RNAs of a typical 
PRRSV strain. The solid blocks at the 5' end of each RNA represent the leader 
sequence. ORFs la and lb can be immediately translated from the positive-strand 
RNA genome. The genome also acts as a template for new genome copies and for 
subgenomic mRNA production. The subgenomic RNAs have a 3'coterminal end 
which includes all of the downstream ORFs, but only the 5' ORF of each subgenomic 
mRNA is believed to be translated. 
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region on LDV and EAV and are assumed to be important for initiating plus-strand 
synthesis of the RNA (Snijder and Meulenberg, 1998). 
The order of viruses in which PRRSV resides, Nidovirales, is named for its 
hallmark replication mechanism which is the formation of a 3' co-terminal nested set of 
mRNAs. For PRRSV this nested set consists of 6-8 subgenomic mRNAs (Conzelmann et 
al., 1993; Meng et al., 1994; Meng et al., 1996b; Meulenberg et al., 1993a; Snijder et al., 
1999). Each of these subgenomic mRNAs also has a conunon S' leader sequence and the 
same 3' terminal sequence including the poly-(A) tail. The leader-mRNA junction 
sequence is conserved and shows a motif of UCAACC or another highly similar sequence 
(Meng et al., 1996a; Meulenberg et al., 1993b). Base-pairing between the leader mRNA 
and the RNA genome is required for production of the sgmRNAs (van Marie et al., 1999). 
These subgenomic mRNAs are polycistronic, but it is believed that only the 5' open reading 
frame of each sgmRNA is translated to a viral protein. 
The genome of PRRSV is positive-strand RNA, and upon infection, it can be 
immediately translated. The ORF lab polycistronic message at the S' end contains the 
RNA-dependent RNA polymerase (RdRp). The polymerase protein is then used to 
transcribe the negative strand complement of the genome, which is able to act as a template 
for new genome copies. The mechanism used to produce the nested set of sgmRNAs has % 
been debated for many years, and currently there are two favored models to explain the 
discontinuous transcription required to generate this unique nested set (Sawicki and 
Sawicki, 1998; van der Most and Spaan, 1995). The first model is referred to as leader-
primed transcription, in which the positive-strand leader is synthesized from the 
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antigenome, dissociates, and then rejoins at a complementary intergenic region acting as a 
primer for sgmRNA synthesis (Baric et al., 1985; Lai et al., 1984; Lai, 1989). In this 
capacity the intergenic sequences would act as both a promoter and a transcription 
initiation site. The second model is known as discontinuous extension of negative strands. 
In this model, as the negative strand is being synthesized the RNA polymerase falls off of 
the template when it pauses at an intergenic sequence and then joins the leader producing a 
negative sgmRNA that serves as a template to produce positive strand sgmRNAs (Sawicki 
and Sawicid, 1990; Sawicki and Sawicki, 1995; Sawicki and Sawicki, 1998). This 
mechanism of site-speciific RNA recombination during negative strand synthesis may be 
guided by distinct RNA structures (van Marie et al., 1999). There is evidence that supports 
both models and the two models are not mutually exclusive of one another, providing 
mechanisms for leader regulation in cis and in trans (van der Most and Spaan, 1995). 
Viral Proteins 
Alter sequencing the 15.1 kb LV genome, it was predicted that open reading fiames 
(ORFs) 2-7 encoded structural proteins and that ORFs la and lb encoded the viral RNA 
replicase gene (Table 1) (Meulenberg et al., 1993a). The proteins have since been further 
characterized and subdivided, with ORFs 5,6, and 7 determined to be the major structural 
proteins encoding the major envelope, matrix and nucleocapsid proteins respectively. 
Replicase gene 
The Arterivirus replicase consists of a two large polyproteins, in PRRSV the genes 
encoding the replicase are about 80% of the genome or nearly 12 kb. ORF la is translated 
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Table 1. Predicted protein functions and nomenciature of PRRSV open reading frames 
ORF Abbreviation Predicted function 
Amino Acid 
Length 
la Nspl Two putative papain-like 
cysteine proteases 
383-385 
Nsp2 Chymotrypsin-like cysteine protease 834-980 
Nsp3 Unknown 446-447 
Nsp4 Chymotrypsin-like cysteine protease 203-204 
Nsp5 Unknown 445-455 
lb RdRp RNA dependent RNA polymerase 645-646 
CP2 Zinc-finger and helicase domains 441-442 
CPS Unknown 223-224 
CP4 Unknown 152-153 
2 GP2 Minor glycosylated envelope protein 246-249 
3 GPS Plighly glycosylated 
Structural protein (Europe) 
Soluble, non-structural (Canada) 
254-265 
4 GP4 Minor glycosylated envelope protein 178-183 
5 GP5(E) Major glycosylated envelope protein 200-201 
6 M Membrane protein 173-174 
7 N Nucleocapsid protein 123-128 
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directly from the gRNA, but a -1 translational frameshift is required for ORF lb expression. 
ORF lb is then expressed as part of the polyprotein ORF lab encodes. EAV and mouse 
hepatitis vims, a coronavirus, have the same arrangement of conserved domains in the 
replicase, which further separates the nidoviruses from the other positive strand RNA 
viruses. The proteolytic processing pathway has been determined for EAV, with ORF lab 
being cleaved 10 times by 3 different ORF la proteases (Snijder et al., 1994; van Dinten et 
al., 1999; Wassenaar et al., 1997). These cleavages and the translational frameshift result 
in 12 end products and a lot of intermediates, some of which have extended half-lives (van 
Dinten et al., 1999). One difference between PRRSV and EAV is that in PRRSV, as well 
as LDV, there is an additional papain-like cysteine protease at the 5' end of ORF la 
(Allende et al., 1999; den Boon et al., 1995; Godney et al., 1993; Meulenberg et al., 1993a). 
There is a highly variable region in the center of non-structural protein 2 (nsp2), which is 
encoded in ORF la. In this region there are major differences among arteriviruses, 
therefore, it has been speculated to be involved in species-specific functions (Allende et al., 
1999; de Vries et al., 1997). There is only 32% amino acid identity and a 120 amino acid 
size difference in the nsp2 protein of the U.S. PRRSV and European LV (Allende et al., 
1999). In U.S. isolate VR-2385, two independent deletions have been detected in the nsp2 
protein. The predominant deletion results in a protein that is 145 amino acids shorter than 
the other U. S. isolates (Morozov unpublished data; Schommer et al., 2000). This variation 
may indicate that the fimction of this protein may involve something other than species 
specificity, because both U.S. and European PRRSV isolates are restricted to pigs. It is 
16 
unknown if differences in this region of the genome are related to differences in 
pathogem'city observed among PRRSV isolates. 
Minor envelope proteins GPs 2.3 and 4 
The nucleocapsid, membrane, and major envelope proteins make up 90-95% of an 
arterivirus particle, so it has been very difficult to characterize the products of ORFs 2-4 
(Snijder and Meulenberg, 1998). ORF 2 of LV was determined to be a 29.5 kDa ^ical 
class I integral membrane glycoprotein with 2 glycosylation sites, but has not been detected 
in a U.S. isolate (Meulenberg and Petersen-Den Bensten, 1996). A disulfide-bond form of 
the ORF 2 protein is retained in the endoplasmic reticulum, but no disulfide linked dimers 
were detected in lysates or extracellular virus, as had been detected with EAV (Meulenberg 
and Petersen-E)en Bensten, 1996). The function of this protein is unknown. However, it 
has been determined that it is indispensable for virus replication because its deletion 
rendered the EAV cDNA clone non-infectious (van Dinten et al., 1997). Recently, an 
additional protein was described in EAV which utilizes a start site upstream of ORF 2. This 
ORF has been named ORF 2b and is found in all arteriviruses. In EAV, LDV, and SHFV 
the start site is located in the region between ORF lb and ORF 2a, previously believed to be 
untranslated. However, in PRRSV the positions of ORF 2a and ORF 2b are reversed and 
the newly recognized start site is 2 nucleotides downstream of the ORF 2a initiation codon 
(Snijder et al., 1999). 
Glycoproteins 3 (GP3) and 4 (GP4) were determined to be minor structural proteins 
in LV by identification with monoclonal antibodies (van Nieuwstadt et al., 1996; 
Wieczorek-Krohmer et al., 1996). However, a Canadian PRRSV stu<fy found that the 
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highly glycosylated ORF 3 protein was non<structural and released as a soluble form (Gonin 
et al., 1998; Mardassi et al., 1998). The ORF 3 protein's function is unknown, but the 
product has been found to be highly antigenic and monoclonal antibodies to the portions of 
the sequence that overlap with ORF 4 are neutralizing in vitro (Duran et al., 1997; Gonin et 
al., 1998; Katz et al., 1995; Meulenberg et al., 1997). In Europe, a GP3 deletion mutant has 
been recently identified and appears to be outcompeting the nondeleted strains without any 
changes in the PRRSV clinical effects. Perhaps analysis of these naturally occurring 
mutants will help elucidate the function of this protein (Oleksiewicz et al., 2000). Little is 
known about GP4 other than it can induce neutralizing antibody activity, further indicating 
that it is a structural protein and that part of it is exposed on the virion surface (Meulenberg 
et al., 1997; van Nieuwstadt et al., 1996). 
Major structural proteins: GPs 5.6 and 7 
GPS has been predicted to be a hydrophobic membrane-associated protein that may 
span the envelope 1 or 3 times, has 2 potential glycosylation sites, and a predicted 32-33 
amino acid signal sequence at the N-terminus (Conzelmaim et al., 1993; Meng et al., 1994; 
Meulenberg et al., 1993a; Snijder and Meulenberg, 1998). Two differently glycosylated 
forms of the protein are found in extracellular virions (Mardassi et al., 1996). Neutralizing 
linear epitopes found on GPS were not affected by the absence of carbohydrate residues 
(Pirzadeh and Dea, 1997). GPS demonstrates a great deal of antigem'c diversity, a property 
that several groups are trying to use to characterize the isolates into serotypes and to map 
the epitopes on this protein (Pirzadeh et al., 1998). It has also been demonstrated that a 
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vaccinia virus recombinant ORF S protein was able to induce apoptosis in cell culture 
(Suarez et al., 1996a). 
The ORP 6 protein is the membrane protein and is the most conserved structural 
protein. A short stretch of only 10-18 amino acids is believed to be exposed, probably 
explaining this conservation and its lack of inmiunogenicity. The ORF 6 protein 
accumulates in the ER until it forms disulfide linked heterodimers with the ORF 5 protein 
(Mardassi et al., 1996). This protein is predicted to play a role in virus assembly and 
budding (Snijder and Meulenberg, 1998). 
ORF 7 encodes the nucleocapsid protein. This protein is found predominantly as a 
disulfide-linked homodimer when immunoprecipitated (Mardassi et al., 1996; Meulenberg 
and Petersen-Den Bensten, 1996). This protein has epitopes that are conserved between the 
U.S. and European PRRSV isolates and is very abundant in cells, making monoclonal 
antibodies to ORF 7 a common diagnostic tool. Currently several groups are mapping 
antigenic sites on this protein, and it is suggested that the C-terminus is important for 
maintaining protein conformation (Meulenberg et al., 1998b; Wootton et al., 1998). Two 
basic regions in the N-terminal half of the nucleocapsid have been putatively identified as 
containing the nuclear localization signal for the PRRSV (Rowland et al., 1999). 
Characterization of PRRSV protein function has just begun. There are now 
monoclonal antibodies to each protein in the 3' end of the genome and an infectious clone 
for both EAV and LV. These tools should help advance this area of research greatiy in the 
next few years. 
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Epidemiology 
According to the current data, it appears that PRRSV entered the swine population 
retativety recently, with the earliest reported clinical outbreaks in 1987, and then spread 
rapidly throughout the world (Hill, 1990). In both North America and Europe there is 
serologic evidence that PRRSV existed before anyone had noticed the clinical signs of the 
syndrome. The earliest known positive serum samples were found during a retrospective 
study in Ontario, Canada. All sera tested from 1978 were negative, while in 1979 3.9% 
were positive and by 1980 15.7% of the herds were positive for PRRSV antibodies 
(Carman et al., 1995). A similar study performed on samples from Iowa showed that 
0/1425 sera samples representing 118 herds were positive for PRRSV in 1980 and that 
3.8% of a smaller sample size were positive in 1985, progressing to 63% of sampled herds 
testing positive in 1988 (Zimmerman et al., 1997b). The low number of PRRSV positive 
herds in 1985 and the fact that the earliest evidence of PRRSV in Minnesota was found in 
sera from 1986, suggests that entry of PRRSV into the U.S. pig population occurred at 
about that time (Yoon et al., 1992b; Zimmerman et al., 1997b). In Germany, serologic 
evidence for PRRSV dates back to 1988, although clinical signs of the syndrome now 
known as PRRS weren't noted until 1990 (Benfield et al., 1999). Despite the fact that 
PRRS seems to have emerged at about the same time on two different continents, antigenic 
and genetic variation between the LT.S. isolates and LV suggest the two viruses either arose 
from two separate sources or shared a common ancestor and diverged some time ago before 
being recognized (Benfield et al., 1999; Kapur et al., 1996). Since that time, PRRSV 
infection has become endemic in most swine producing areas. 
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The origin of PRRSV is unknown. The only animals reported to be naturally 
infected by PRRSV are feral and domestic swine. One study demonstrated that some avian 
species could be infected with PRRSV and were shown to shed the virus in their feces for 
25 days post-infection (Zimmerman et al., 1997a). Mallard ducks were found to be able to 
transmit virus to each other and to swine, suggesting a potential involvement in PRRSV 
spread but it is probably not a major participant (Zimmerman et al., 1997a). Rodents, 
which are more commonly associated with pigs in their natural environment, were not able 
to be infected by the virus and no other vectors or animal reservoirs have been documented 
(Hooper et al., 1994). 
PRRSV is highly infectious while being, relatively speaking, not highly contagious. 
Swine are readily infected by 10 or less infectious virus particles by both the intranasal and 
intramuscular routes, yet it may take weeks or months for all the pigs in a herd to become 
infected. (Benfield et al., 1999). Herds can remain infected after cessation of symptoms, 
making clim'cally normal carriers an important source of PRRSV infection, particularly 
when adding replacement stock. The predominant route of PRRSV transnussion is direct 
contact, but in at least one experiment even direct contact did not facilitate infection with 
only 2 of 8 contact controls becoming positive for PRRSV (Christianson et al., 1992; 
Collins et al., 1992; Terpstra et al., 1991; Torremorell et al., 1997; Wensvoort et al., 1991). 
Aerosolized virus was originally believed to be a major source of infection since PRRSV is 
found in the upper respiratory tract. This mode of transmission has been very difficult to 
achieve experimentally, however, and even pigs only 40 inches away firom infected pigs 
were much less likely to become infected than those pigs in direct contact (Wills, 1997; 
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Wills et al., 1994). Artificial insemination and semen have also been demonstrated to 
cause transmission of PRRSV to naive animals (Shin et al., 1997; Swenson et al., 1994b; 
Yeager et al., 1993). 
Potential routes of the excretion of PRRSV have been studied in experimentally-
infected animals (Wills et al., 1997a). Urine and feces had been reported to contain virus, 
but other reports have shown that shedding in feces does not occur at all or may only 
intermittently occur (Rossow et al., 1994; Wills et al., 1997a; Yoon et al., 1993). PRRSV 
was isolated from saliva 42 days post-infection (DPI), urine 14 DPI, and semen 43 DPI 
(Swenson et al., 1994a; Wills et al., 1997a). Although PRRSV is fairly labile in the 
environment, LV was demonstrated to have an infectious half-life of 140 hours at 4 °C and 
a pH of 7.5, and virus could be isolated from city water after 11 days (Bloemraad et al., 
1994; Pirtle and Beran, 1996). Therefore, slurry and contaminated water may serve as 
sources of PRRSV infection (Pirtle and Beran, 1996; Wills et al., 1997a). 
Modified live virus vaccines (MLV) have been developed in an effort to control 
PRRSV. Live vaccines replicate in vivo and virus is shed from vaccinated animals. There 
is potential danger of recombination with field isolates, as well as danger of reversion of 
the vaccine virus to a more virulent form. Several studies in both the U.S. and Dermiark 
have suggested that h've PRRS vaccine virus can revert to virulence under field conditions 
(Boetner et al., 1997; Mengeling et al., 1999b; Storgaard et al., 1999). Due to the extreme 
antigenic and genetic sequence differences between U.S. and European PRRSV isolates, it 
has been relatively easy to follow the spread of a U.S. PRRSV vaccine in Denmark 
(Storgaard et al., 1999). Unfortunately this lack of antigem'c relatedness may have 
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contnbuted to the unexpected spread of clinical disease following use of the vaccine in 
Denmark. 
Clinical Signs 
As the name porcine reproductive and respiratory syndrome implies, clinical signs 
fall into two main categories, reproductive signs and respiratory effects. Clinical signs of 
PRRS are extremely variable in both field and experimental conditions, with a transient 
fever and inappetence being the most consistent clinical change (Halbur et al., 1996b; 
Halburetal., 1995b; Keflfaber, 1989; Wensvoort, 1993; White, 1992). Reproductive signs 
of infection caused by PRRSV are characterized as late-term abortions, late-term in utero 
death, mununified fetuses, increased stillbirths, and weak-bom piglets (Christianson et al., 
1992; Mengeling et al., 1994; Plana etal., 1992; White, 1991). Signs of PRRSV infection 
may also be observed as decreased farrowing rates, delayed returns to estrus, and increased 
infertility increasing the amount of time sows are open and requiring repeat services 
(Keffaber, 1989; Loula, 1991). Reproductive problems may persist in a herd for 4-5 
months, which is longer than an entire reproductive cycle, and the herds often become 
enzootic at that point (Done et al., 1996). Infected adult animals may present with 
anorexia, fever, lethargy, and sometimes transitory skin discoloration (Christianson, et al., 
1992; Mengeling et al., 1994; Park et al., 1996; Plana et al., 1992; Terpstra et al., 1991; 
White, 1991). Occasionally there may be mortality of adult pigs with some herds 
experiencing a 3-4% loss of sows (Loula, 1991), recently a more virulent form of PRRS 
was described in which mortality rates were as high as 10% (Benfield et al., 1999; Loula, 
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1991). The new, highly virulent PRRSV strains also caused a high prevalence of congenital 
infection and marked clinical ilbess in gilts in contrast to strains previously studied by the 
same research group (Mengeling et al., 1999a). Boars infected by PRRSV may show 
inappetence, lethargy, fever and respiratory signs (Loula, 1991). A decrease in the semen 
quality &om infected boars may or may not contribute to the increased infertility on 
infected farms (Christopher-Hennings et al., 1997; Prieto et al., 1996b; Sur et al., 1997; 
Swenson et al., 1994a; Yeageretal., 1993). 
Piglets bom to infected sows are often weak and may show an abnormal doming of 
the head (Gordon, 1992). An increase in pre-weaning mortality, which may be as high as 
60% usually accompanies PRRSV outbreaks (Benfield et al., 1999; Stevenson et al., 1993). 
Nearly all premature pigs die within hours of birth and surviving piglets are often 
considered "poor doers" and may exhibit splay legs, a rough hair coat, decreased appetite, 
and rapid abdominal breathing (Loula, 1991). Central nervous signs in neonatal pigs have 
also been reported including paddling and tremors (Keffaber, 1989; Loula, 1991; Rossow et 
al., 1999). Suckling and nursery pigs may exhibit lethargy, dyspnea, and hyperpnea. 
Weaned pigs may have a reduction in feed efQciency and an increase in secondary 
infections causing a large variation in size of age-matched groups of pigs (KefTaber, 1989; 
Loula, 1991; Stevenson et al., 1993; White, 1992). Respiratory signs may be accompanied 
by swelling of the eyelids and conjunctiva (Van Alstine et al., 1993; White, 1992). PRRS-
associated diarrhea is common in Britain, but has rarely been associated with PRRS in 
other countries (Gordon, 1992; Goyal, 1993; Hopper et al., 1992; White, 1992). The 
sevens of PRRS generally decreases with increased age of the pig and may go undetected 
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at any age unless accompanied by a secondary bacterial or concurrent viral in^tion 
(Goyal, 1993; Joo and Dee, 1993; Van Reeth, 1997). Secondary infections are conunonly 
associated with PRRSV in the field and can contribute to the degree of clinical signs 
observed. PRRSV-induced pneumonia is significantly prolonged and more severe when 
there is a concurrent infection with h/fycoplasma hyopneumoniae (Thacker et al., 1999). 
Severe respiratory disease has only been reproduced using U.S. isolates and there is 
considerable variability in the severity of respiratory disease induced by U.S. isolates 
(Halbur et al., 1995b; Rossow et al., 1995; Van Reeth, 1997). 
Gross and Microscopic Pathology 
Viral pathogenesis is based primarily on the cell type in which replication occurs. 
For PRRSV, cells of the monocyte/macrophage lineage are infected (Halbur et al., 1996a; 
Rossow et al., 1995; Voicu et al., 1994; Wensvoort et al., 1991). PRRSV antigen or RNA 
is detected in the macrophages of most tissues as well as in monocytes, endothelial cells, 
glial cells, and dendritic cells (Halbur et al., 1995a; Haynes et al., 1997; Larochelle and 
Magar, 1995; Magar et al., 1993; Pol et al., 1991; Rossow et al., 1996a; Sur et al., 1996). 
Most PRRSV replication is beh'eved to occur in macrophages at the mucosal surface, with 
the virus being distributed to other tissues by the lymphoid system and subsequently found 
systemically (Rossow etal., 1995). 
Reproductive Pathology 
Several in vivo studies have been done to determine if time of gestation is important 
for the reproductive failure seen in PRRSV infection. Inoculation of gilts or sows has 
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resulted in transplacental infection from 30 - 95 days of gestation, with fetal lesions 
occurring only if infection is after 77 days of gestation (Chnstianson et al., 1992; 
Christianson et al., 1993; Dea et al., 1992; Lager and Ackermann, 1994; Mengeling et al., 
1994; Plana et al., 1992; Terpstra et al., 1991; Wensvoort et al., 1991; Yoon et al., 1992b). 
It had been observed previously that infection at mid-gestation did not seem to have the 
same consequences, so a study was done to define when this change in manifestation took 
place (Chnstianson et al., 1993). Several methods of inoculation including intranasal 
inoculation of the sow, intravenous inoculation of the sow, and direct inoculation of the 
fetal amnion were used to determine if it was a change during fetal development or the 
placental barrier preventing fetal infection during early gestation (Lager and Mengeling, 
1995). No decrease in fertility or increase in abortions was observed when gilts were given 
an intrauterine dose of PRRSV at or near conception (Lager and Halbur, 1996; Prieto et al., 
1996a). In contrast, semen spiked with PRRSV and used to inseminate gilts had little 
effect on conception, but resulted in embryonic death prior to 20 days post-infection (Prieto 
et al., 1997). It was found that fetuses infected in the first half of gestation, up to 31 days, 
could replicate vims without severe pathological consequences and that fetuses at all stages 
of gestation could support PRRSV replication (Christianson et al., 1993; Lager and 
Mengeling, 1995). Directly inoculating the amnion with PRRSV in the second half of 
gestation could result in fetal death within days (Lager and Mengeling, 1995). Previous 
speculation of intrauterine spread was confirmed by directly infecting some fetuses in the 
uterus, while leaving others as uninfected controls. Some control fetuses became PRRSV 
positive, possibly due to an ability to cross the placental barrier in association with 
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maternal macrophages, but it was not possible to determine whether fetus-fetus or fetus-
dam-fetus spread of the virus was taking place (Christianson et al., 1992; Lager and 
Mengeling, 1995). Using intranasal inoculation of the dam, it was found that the ability of 
PRRSV to spread transplacentally was also time dependent At 30 days gestation there was 
no transplacental infection, limited infection at 50 and 70 days, and late term abortions 
were caused by infection at 90 days gestation (Lager and Mengeling, 1995). These studies 
suggest that although the fetus is capable of replicating virus at 31 days of gestation, isolate 
VR-2332 was incapable of crossing the placenta in order to cause infection at this time. 
This is likely due to the changes in the layers that separate fetal and maternal blood which 
are brought closer together later in gestation making for a more efficient exchange 
(Christianson et al., 1993). 
It is often difBcult to demonstrate the presence of PRRSV in the fetuses of infected 
sows, due to the instability of the virus in autolyzed tissue and depending on the gestation 
stage at infection (Mengeling et al., 1994). The most consistent gross abnormality observed 
in fetuses containing virus was a sticky meconium staining (Lager and Halbur, 1996). 
Stillbirths and weak-bom piglets from infected sows had an abundance of clear liquid in the 
thoracic cavity (Lager and Halbur, 1996; Plana et al., 1992). Some placenta had brown-tan 
discoloration and other normal appearing placenta were separating from the uterus (L^er 
and Halbur, 1996). The only fetal lesion that has been reported consistently is perivascular 
hemorrhage of the umbilical cord (Done et al., 1996; Lager and Halbur, 1996). Many 
infected fetuses had this gross lesion which included segments of hemorrhagic areas 1-2 cm 
in length to full length involvement of the cord. Necrotizing arteritis and periarterial 
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hemorrhage may also be observed. Sometimes there was no hemorrhage, but the cord was 
edematous and enlarged 2-3 times normal size. All fetuses showing gross umbilical cord 
lesions were viremic, and it was postulated that blood flow disruption may cause hypoxia 
leading to death for some of the fetuses (Lager and Halbur, 1996). 
Microscopic uterine and placental changes have been observed in some animals, but 
there is limited evidence for viral replication at these sites (Christianson et al., 1992; 
Stockofe-Zurwieden et al., 1993). Mild lymphoplasmacytic inflammation, endometritis 
and myometritis were observed in experimentally-infected gilts (Christianson et al., 1992; 
Lager and Halbur, 1996). In the fetus, microscopic examination sometimes reveals 
myocarditis, interstitial pneumonia, vasculitis, and encephalitis (Rossow et al., 1996b). 
Respiratorv Patholoev 
Gross pneumonia consisting of multifocal areas with irregular indistinct borders 
giving lungs a mottled tan or red appearance have been described in natural and 
experimental infection (Halbur et al., 1996b; Halbur et al., 199Sa). In experimental studies, 
obvious differences in the severity of gross lung lesions generally correlated with the 
severity of clinical disease and usually peaked at 10-14 DPI, but can be seen as early as 4 
DPI (Beyer et al., 1998; Halbur et al., 199Sb). Generally speaking gross lung lesions 
caused by PRRS V are more severe in younger pigs, making it less likely that gross lesions 
will be observed in grower-finishers or adult pigs. Enlarged lymph nodes that are 3-10 
times normal size, tan, and edematous with multiple cysts containing clear fluid are a 
consistent gross sign of PRRSV infection and can be observed in pigs of all ages (Halbur et 
al., 1995b; Rossow et al., 1994; Rossow et al., 1995). 
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The hallmark of PRRSV is a characteristic interstitial pneumonia. These 
microscopic lesions are usually present even when gross lesions are absent. Histological 
changes of mild, multifocal, interstitial pnuemonia can be noticed as early as 2 DPI (Beyer 
et al., 1998; Pol et al., 1991). There are several halhnark characteristics of PRRSV 
interstitial pneumonia that are consistently observed in field cases and described after 
experimental infection of colostrum-deprived-cesarean-derived (CDCD) and gnotobiotic 
pigs (Halbur et al., 1995b; Rossow et al., 1995). The three most consistent lesions are 
marked septal thickening from infiltration by macrophages and lymphocytes, Qrpe-2 
pneumocyte hypertrophy and hyperplasia, and alveolar lumina filled with inflammatory 
cells and necrotic debris (Halbur et al., 1995b; Rossow et al., 1995). Mild to moderate 
peribronchial and perivascular lymphohistiocytic cuffing has been described, with the 
unaffected bronchi and bronchiolar epithelia (Halbur et al., 1995a; Halbur et al., 1995b). 
These characteristics are observed in varying degrees in experimental infections with both 
high and low virulence isolates (Halbur et al., 1996b). 
PRRSV antigen is widespread throughout the respiratory and lymphatic systems 
within 24-48 hours of infection. Immunohistochemistry has also confirmed PRRSV in the 
endothelial cells of the heart and intestine (Halbur et al., 1996a). PRRSV infected pigs may 
also show an accumulation of lymphocytes in nasal turbinates and lymphoid depletion in 
the lymphoid tissue including spleen, thymus, tonsil and lymph nodes (Done and Paton, 
1995; Pol et al., 1991). Microscopically, lymph nodes are reactive, with follicular 
hyperplasia and hypertrophy, and have foci of necrosis in the center of lymphoid follicles 
(Halbur et al., 1995b; Rossow et al., 1995). In one study, polykaryocytes were observed in 
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the lymph nodes (Rossow et al., 1995), but this has not been described in infections with 
other PRRS V isolates. It has since been suggested that these pigs may have also been 
infected with porcine circovirus (Ellis et al., 1999; Rossow et al., 1995). 
Less consistent lesions in several different tissues have also been described. Some 
researchers have reported rhinitis, encephalitis, and myocarditis, primarily in neonatal pigs 
(Halbur et al., 1996b; Rossow et al., 1994; Rossow et al., 1995). Histiocytic perivascular 
cuffing has been described in the brain (Halbur et al., 1995b). Severe lymphoplasmacytic 
interstitial nephritis with vasculitis has also been reported (Cooper et al., 1997; Stevenson 
etal., 1993). 
Immunology 
Early studies into the immunologic response to PRRSV focused on the humoral 
response which can be examined using relatively simple methodologies including indirect 
fluorescent antibody test (IFA), enzyme-linked immunosorbent assay (ELISA), 
immunoperoxidase monolayer assay (IPMA), or a serum vims neutralization test (SVN). 
PRRSV specific IgM antibody can be detected by 5 days post-infection (DPI), peaks at 14-
21 DPI, and is undetectable by 35-42 DPI (Loemba et al., 1996; Venzia et al., 1996). Anti-
PRRSV IgG antibodies develop by 7-10 DPI, with those reacting with the N protein 
appearing first and those antibodies to the GP5 and M protein appearing by 9-14 DPI 
(Albina et al., 1994; Christianson et al., 1992; Christianson et al., 1993; Nelson et al., 1994; 
Park et al., 1995; Stevenson et al., 1994; Yoon et al., 1992a; Yoon et al., 1994). PRRSV-
specific antibodies decay by approximately 137 DPI by IFA and 356 DPI by SVN (Yoon et 
30 
al., 1995a). Neutralizing antibody can be detected 9-105 DPI and often exists concurrently 
with viremia (Christianson et al., 1992; Lager and Ackermann, 1994; Loemba et al., 1996; 
Stevenson et al., 1994; Yoon et al., 1995a). Monoclonal antibodies to ORFs 4 and 5 have 
been demonstrated to neutralize PRRSV, indicating that these two proteins may be 
important for viral infectivity (Meulenberg et al., 1997; Prizadeh and Dea, 1997). There is 
no correlation between neutralizing antibody response and viremia, suggesting that it is 
probably not an essential part of the immune response (Loemba et al., 1996). The presence 
of low levels of virus specific antibody has actually been demonstrated to enhance PRRSV 
infection (Yoon et al., 1994; Yoon et al., 1996). There is some protective immunity 
however, since previously infected sows don't transmit virus to their fetuses or suffer 
reproductive failure when rechallenged late in gestation (Gorcyca et al., 1993; Lager and 
Ackermann, 1994). 
PRRSV causes a degeneration of alveolar macrophages, not unexpectedly since this 
is the target cell of the virus. Molitor and others (1992) have reported that there is a 
startling decrease in the number of macrophages collected by lung lavage after PRRSV 
infection. In normal pigs 90% of the cells collected in this manner are alveolar 
macrophages, but in acutely infected pigs they make up only 50% of the cells, with a 
relative increase in lymphocytes and neutrophils (Molitor et al., 1992). Experimental 
infection with PRRSV isolate VR-2332 resulted in a decrease in blood monocytes and 
lymphocytes, especially in T- lymphocytes. The decrease in T-lymphocytes was first seen 3 
days post-infection and had returned to normal by 14 days after infection (Christianson et 
al., 1992). Along with the destruction of alveolar macrophages, PRRSV induces a dramatic 
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increase in inflammatory cytokine expression and suppression of nonspecific bactericidal 
activity, such as the ability to release superoxide anion (Halbur et al., 1996a; Molitor et al., 
1995; Thanawongnuwech et al., 1998). The inflammatory response can account for the 
increase number of mononuclear cells seen in the lung. The suppression of nonspecific 
bactericidal activity when combined with the transient decrease in T-lymphocytes, helps 
explain the perceived predisposition to secondary bacterial infections. 
Since neutralizing antibody does not appear to be the major factor in controlling 
PRRSV infection, recent studies have examined the cellular immune response, bnmunity 
to PRRSV can be transferred via colostrum, but antibody alone was not totally protective, 
further suggesting the role of cellular immunity (Molitor et al., 1997). Antigen specific 
lymphocyte proliferation was observed at 28 DPI, peaked at 49 DPI, and declined by 77 
DPI (Bautista and Molitor, 1997). and CD'* cells have been shown to increase in 
number after PRRSV infection (Albina et al., 1998; Bautista and Molitor, 1997; Shimizu et 
al., 1996). The proliferation of CD '^*' cells was shown to coincide with the decrease in 
viremia observed at 3-4 weeks post-infection, indicating this cell type may play a role in 
clearing the virus, as they are the precursor of cytotoxic T-lymphocytes (Albina et al., 
1998). T-cell responses are also boosted to proliferation upon second exposure to the virus 
and administration of antibodies to CD^*^ and CD^"^ cells resulted in a major inhibition of 
the proliferative response to PRRSV /n vitro (Bautista and Molitor, 1997). ORFs 2,4,5, 
and 6 induced T-cell proliferation in vitro when proteins expressed in vaccim'a virus were 
used as antigen (Bautista et al., 1999). Overall ORF 6 elicted the greatest response. 
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indicating that this protein may play a major role in cell-mediated immunity (Bautista et al., 
1999). 
There is some debate as to whether or not PRRSV causes immunosuppression. The 
observation that secondary infections are conmionly associated with PRRSV in the field, 
combined with the fact that the virus infects cells of the immune system, led to speculation 
that suppression of the immune system may occur. Infections by Streptococcus suis, 
porcine respiratory coronavirus, and swine influenza virus are exacerbated by PRRSV 
infection, while the systemic humoral and cell-mediated response to pseudorabies virus and 
Escherichia coli was enhanced (Galina et al., 1994; Molitor et al., 1992). This has led to 
the speculation that PRRSV may cause transient local inmiune impairment, but not general 
immunosuppression (Wensvoort et al., 1992). 
Persistence 
Persistence of RNA viruses has been defined as the continued presence of virus 
within a host for extended periods of time after acute infection (Ahmed et al., 1996). 
Persistence in PRRSV infections is important at both a pig and herd level. Infectious virus, 
viral RNA, and viral antigen have been shown to be present in pigs for an extended period 
of time after serum antibodies have been detected and clinical signs have subsided 
(Christopher-Hennings et al., 1995; Swenson et al., 1994a; Wills et al., 1997b). 
Transmission by direct contact with susceptible animals has been demonstrated using sows 
infected 99 days prior to their exposure to the muve animals (21immerman et al., 1992). 
Another study showed that animals stressed and given corticosteroids 22 weeks after 
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infection could transmit virus to naive specific pathogen free (SPF) pigs, even though a 
similar unstressed group was unable to infect sentinel pigs at 13 weeks post-infection 
(Albina et al., 1994). The presence of viral RNA has been demonstrated, using PGR, in 
semen at 92 DPI, although serum from the same timepoint was negative (Christopher-
Hennings et al., 1995). Previously, infectious virus was found to be present in serum for 43 
days following PRRSV exposure (Swenson et al., 1994a). Oropharyngeal scrapings have 
been shown to harbor infectious virus the longest of any tissue studied so far, with PRRSV 
isolation at 157 DPI, 134 days after virus was last isolated from serum in that animal (Wills 
et al., 1997b). There does not appear to be any conrelation between the pathogenicity of an 
isolate and its ability to persist, as several isolates including a vaccine strain have been 
shown to persist equally well (Halbur et al., 1995b; Mengeling et al., 1996). 
Persistence within a herd is more difBcult to study experimentally, therefore most of 
the information available is based on epidemiological studies. In one swine operation, a 
PRRSV strain isolated 4 months after the disappearance of clinical signs from that herd was 
found to remain highly virulent when used to inoculate naive sows (Bilodeau et al., 1994). 
There are many theories as to how PRRSV is able to persist in an operation including: 1) 
incomplete infection of susceptible pigs during the acute phase of the disease, thus leaving 
susceptible animals; 2) introduction of susceptible pigs as replacements; 3) persistent 
infections in individual animals that may be induced to shed virus when stressed; 4) 
variable decreases in active and passive immunity (Albina et al., 1994). The two key 
components in maintaining PRRSV endemically appear to be the presence of clinically 
normal carriers and the continual introduction of susceptible animals (Wills et al., 1997b). 
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Diagnosis 
Diagnosis of PRRSV infection can be made based on clinical signs, gross lesions, 
and histopathology, but these pathological examinations are rarely used alone for a 
definitive diagnosis. As previously discussed, many animals and herds infected with 
PRRSV have only subclinical signs, so the absence of signs and lesions does not necessarily 
mean that those animals are PRRS V-free. Many standard testing methods are now 
available for aid in PRRSV diagnosis. 
Serological tests for antibody to PRRSV are often done using a conunercial ELISA 
(Albina et al., 1992) that is available from IDEXX, but may also be done by IFA (Park et 
al., 1995; Yoon et al., 1992a), IPMA (Wensvoort et al., 1991; Wensvoort et al., 1992), or a 
SVN (Hill et al., 1993; Takikawa et al., 1997; Yoon et al., 1994). PRRSV antibodies can 
be detected as early as 5 days post-infection and reach maximal titers by 30-50 days post­
infection, at which point antibody levels begin to decline (Albina et al., 1994; Christianson 
et al., 1993; Park et al., 1995; Yoon et al., 1992a; Yoon et al., 1994; Yoon et al., 1995a). 
The SVN test has been modified to identify neutralizing antibody earlier by adding 20% 
fresh swine serum, enabling detection as early as 9 DPI (Yoon et al., 1994). At this time, 
there is no serological test that is able to differentiate between an infection by a field strain 
or vaccination, and antibody alone does not confirm the presence of an acute infection 
since PRRS is endemic in the swine population. To help determine if an infection is acute, 
paired sera several weeks apart should be tested. In a diagnostic laboratory setting, the 
ELISA is most likely to be used since it can be automated and has a similar specificity, 
wider isolate detection range, and greater sensitivity than IFA or IPMA (Cho et al., 1996). 
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A blocking ELISA has also been developed that has decreased background and is more 
sensitive than IPMA or indirect ELISA (Houben et al., 1995; Sorensen et al., 1997). 
Despite the limitations, serological testing is the most efficient way to screen a herd for 
PRRSV, using a sample size of 30 animals will allow a 95% confidence of detecting 
antibodies if there is a seroprevalence of 10% or more (Dea et al., 1992). 
Methods for detecting the presence of viral antigen in tissues include 
inmiunohistochemistry (IHC), commonly performed on fixed tissue, and IFA, commonly 
used for frozen tissues (Halbur et al., 1994; Lager and Ackermann, 1994; Larochelle and 
Magar, 1995; Yoon et al., 1992b). There are also tests that identify viral RNA such as in 
situ hybridization (ISH) and RT-PCR (Chueh et al., 1999; Haynes et al., 1997; Larochelle 
and Magar, 1997; Sur et al., 1996). IHC, IFA, and ISH all allow the localization of the 
virus to be visualized in tissues, which is helpful in correlating lesions in an infected animal 
to the agent causing the lesions. In situ hybridization has the added benefit of being able to 
differentiate between North American and European isolates (Larochelle and Magar, 1997). 
A disadvantage to IHC, IFA, and ISH is their dependence on technician skill in performing 
and interpreting the tests. 
Virus isolation can be done from serum, lung lavage, or tissue samples to confirm 
the presence of an active infection of PRRSV. Different isolates have differing abilities to 
replicate in the various cell Q^s used to propagate PRRS, in order to maximize isolation 
from positive animals both PAMs and a cell line should be used (Bautista et al., 1993b). 
Cocultivation of PAMs from infected pigs with MARC-145 cells has been shown to be a 
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sensitive method for PRRSV detection, with virus isolated at 63 DPI as compared to 28 
DPI from serum (Mengeling, 1996). 
RT-PCR can be used to differentiate different strains of virus and has a maximum 
sensitivity of less than 10 viral particles, depending on the exact sample and primers used 
(Christopher-Hennings et al., 1995; Guarino et al., 1999; Mardassi et al., 1994; Oleksiewicz 
et al., 1998b; Suarez et al., 1994; Van Woensel et al., 1994). This technique is especially 
useful for detecting PRRSV in samples that are not good for virus isolation such as semen 
and partially autolyzed fetal tissue (Christopher-Hennings et al., 1995). A modification of 
RT-PCR, restriction fragment length polymorphism (RFLP) has come into use as a method 
of not only identifying that PRRSV is present, but for differentiation of the isolates found 
(Gagnon and Dea, 1998; Wesley et al., 1998). This technique has quicldy become the most 
common method for differentiating the RespPRRS/Repro^** vaccine strain from field strains 
(Wesley et al., 1998). 
Clinical signs, gross lesions, and microscopic lesions are important in identifying 
that the disease being observed is actually caused by the virus. While this may not always 
be possible due to the often subclinical presentation of PRRS, without these observations it 
may indicate that another agent is actually responsible for the clinical disease observed. 
This is especially important when using serology, which may indicate exposure to a virus 
the animal has long since recovered from, and RT-PCR which is so sensitive it may identify 
animals not being affected by the virus. 
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Variation among PRRSV Isolates 
Variations in Virulence 
The clinical signs of PRRS vary significantly in both natural and experimental 
infections. This variation is due to a variety of factors related to the environment, the host, 
and the virus itself Environmental factors are the most controllable factors for preventing 
a severe outbreak and include pig density, pig movement, air quality, and housing system 
(Dee, 1992). Pig age, breed, and genetics may contribute to pig-to-pig differences in 
susceptibility (Halbur et al., 1998; Thanawongnuwech et al., 1998). Herd health status, 
especially the presence of secondary infections, can influence the severity of clim'cal signs 
observed in a given herd (Dee, 1992; Van Reeth, 1997). The virus isolate that infects the 
animal plays a significant role in determining the clinical signs and their severity (Meng et 
al., 1995a; Meng et al., 1995b; Van Reeth, 1997; Yoon et al., 1999). Under experimental 
conditions, the dose of virus an animal is exposed to has also been demonstrated to 
influence disease severity (Yoon et al., 1999). 
Variations in virulence due to differences in the PRRSV strain infecting the host 
have been well characterized. European and U. S. PRRSV isolates represent two genotypes 
and the differences in clinical manifestations caused by each reflect the genetic differences. 
In Europe, PRRS is commonly accompam'ed by scouring and a bluish discoloration of the 
ears or vulva, whereas these signs are rarely reported in the U.S. (Done and Paton, 1995). 
Differences in reproductive and respiratory pathogenicity have been demonstrated among 
U.S. PRRSV isolates and in comparison to those from Europe (Halbur et al., 1996b; Halbur 
et al., 1995b; Mengeling et al., 1996; Park et al., 1996). Gross lung lesions in CDQD pigs 
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provide an excellent parameter for comparing the virulence of isolates and their severity 
correlates well with clinical disease severity (Halbur et al., 1996b; Halbur et al., 1995b). 
The severity of the reproductive effects of a PRRSV isolate did not directly correlate with 
the severity of respiratory disease caused by the same isolates (Mengeling et al., 1996). 
Lymphadenopathy, viremia and viral persistence were observed consistently with all virus 
isolates despite their differences in virulence (Halbur et al., 1996b; Halbur et al., 199Sb; 
Mengeling et al., 1996). The demonstrated differences in pathogem'city due to PRRSV 
isolate variation may help explain the variability of disease seen in the field (Halbur et al., 
1996b; Halbur et al., 1995b; Mengeling et al., 1996). 
Antigenic Variation 
It has been demonstrated that despite the wide genetic diversity between U.S. and 
European isolates that all the isolates share some conmion antigem'c epitopes, yet are 
antigenically distinct (Nelson et al., 1993; Wensvoort et al., 1992). This has been 
ascertained from the observation that while two monoclonal antibodies raised against the 
highly conserved nucleocapsid (N) protein of U.S. PRRSV isolates cross-reacted with the 
European PRRSV isolates, several others did not (Nelson et al., 1993). One of those cross-
reactive monoclonal antibodies, SD0W17, reacts with an extensive number of U.S. and 
Canadian PRRSV isolates, as well as European isolates representing 8 countries (Magar et 
al., 1997; Nelson et al., 1993). However, at least 1 U.S. isolate was found to lack reactivity 
with the broadly reacting antibody (Yoon et al., 1995b). 
Serum samples, submitted to a diagnostic laboratory from 18 U.S. states were tested 
for the presence of antibody that recognized U. S. and European PRRSV isolates. Of the 
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837 samples tested, 20% of the PRRSV sera reacted with only Lelystad virus, 44% reacted 
with VR-2332 only, and 36% reacted with both (Bautista et al., 1993a). This indicates that 
either some Lelystad virus is found in the United States or that there is so much vahation in 
antigenicity among U.S. isolates that some isolates can't react with VR-2332, but can react 
with the less closely related European isolate. Serum antibody response to homologous 
PRRSV isolates can be detected earlier after infection than antibody that cross-reacts with 
heterologous virus (Bautista et al., 1993a). When animals were infected with U.S. PRRSV 
isolate VR-2332, antibo<fy that cross-reacted with Lelystad virus was not detected until 63 
DPI (Bautista et al., 1993a). This serological survey may underestimate the percentage of 
PRRSV infected pigs producing antibody that reacts with both U.S. and European isolates, 
since most serum samples submitted to a diagnostic laboratory would be submitted during 
acute infection. 
Recently an antibody mapping system was tested using monoclonal antibodies to 
the highly conserved nucleocapsid protein. Sixty-seven North American field isolates 
from prior to 1996,2 modified live vaccine strains, and the Lelystad virus were analyzed 
for their reactivity to the monoclonal antibody panel. All the isolates were assigned to one 
of 5 antigenic groups, with Lelystad forming its own unique group. Surprisingly, less 
antigenic diversity was found among the field isolates than expected, with 84% of the 
isolates sorting into the same antigenic group (Yang et al., 1999). This may be due to the 
samples being nonrandom geographically, may indicate that after the initially diverse 
PRRSV population only some seroQrpes predominated by 1996, or may indicate that the 
nucleocapsid protein is too conserved to adequately separate the various isolates. North 
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American isolates may be more antigenically diverse than that study demonstrated, 
regardless of year of isolation, if antibodies to proteins other than the nucleocapsid are 
looked at, such as monoclonal antibodies to the membrane protein (Dea et al., 1996). A 
panel of monoclonal antibodies recognizing different PRRSV proteins can be used to 
further study antigenic variation and to differentiate PRRSV isolates (Jones et al., 1999; 
Magar et al., 1997). 
Genetic Variation 
PRRSV has an RNA genome, increasing the likelihood that the viral genome will be 
genetically diverse. Synthesis of RNA is error prone and the discontinuous nature of 
PRRSV replication makes this virus especially likely to undergo recombination (Lai, 1996; 
Yuan et al., 1999). Studies have clearly indicated that there are two distinct genotypes of 
PRRSV, the European and North American, and probably several minor genotypes within 
North America (Kapur et al., 1996; Meng et al., 1994; Meng et al., 1995a; Meulenberg et 
al., 1993a; Murtaugh et al., 1995). The currently described Asian PRRSV isolates are 
related to the North American genotype (Saito et al., 1996). 
North American isolates are genetically distant from the European isolates, sharing 
only about 60% of their amino acid sequence in ORFs 2-7 (Conzelmann et al., 1993; Meng 
et al., 1995a; Meng et al., 1995b; Meulenberg et al., 1993a). There is also genetic diversity 
within each of the PRRSV genotypes. Eight U.S. isolates of varying pathogenicities were 
compared by sequencing the structural proteins, membrane (NQ and nucleocapsid (N) genes 
were 96-100% identical among the isolates (Meng et al., 1995a). ORFs 2,3,4 and 5 were 
about 90% identical, overall ORFs 3 and 5 were the most variable and ORF 6 was the most 
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conserved (Kapur et al., 1996; Meng et al., 1995b). ORFs 5 and 7 were compared among 
European countries and it was found that there was 95-100% amino acid identity in ORF 7 
and 88% in ORF 5 (Suarez et al., 1996b). The results of amino acid sequence comparisons 
within the North American genotype and between the North American and European 
genotypes are summarized in Table 2 (Andreyev et al., 1997; Kapur et al., 1996; Meng et 
al., 1995a; Meng et al., 1995b; Meulenberg et al., 1993a). 
Due to the great deal of variation between the different strains of PRRSV, it has 
been difficult to identify particular amino acids or even regions of the genome that are 
responsible for the differences observed in pathogem'city. Basic studies on the functions of 
the different PRRS viral proteins have just begun to be reported. Previously most of the 
attention to PRRSV genetic variation has been related to the corresponding differences in 
Table 2. Amino Acid identity among North American PRRSV isolates and between North 
American isolates and Lelystad Virus 
Protein North American isolates Lelystad Virus 
Replicase(la) 88-99 32-62 
Replicase (lb) 97-99 42-75 
GP2 91-99 57-62 
GP3 87-98 55-60 
GP4 92-98 65-67 
Envelope (GP5) 85-99 51-58 
Membrane 96-100 78-81 
Nucleocapsid 96-100 57-60 
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antigenicity that result from this variation, thus focusing on ORF 5 (Andreyev et al., 1997; 
Kapur et al., 1996). Since it appears that neutralizing antibody is not the main mechanism 
of PRRSV clearance (Christianson et al., 1992; Lager and Ackennann, 1994; Loemba et al., 
1996; Stevenson et al., 1994; Yoon et al., 1995a), it is likely that there are other viral 
factors responsible for differences in viral virulence. The use of a single isolate of PRRSV 
at different cell passages, decreases the number of random background genetic mutations 
that would normally be seen when sequencing two completely different isolates. An 
infectious clone would then be useful in testing the potential virulence determinants of 
PRRSV. Currently an infectious clone exists for LV (Meulenberg et al., 1998a), but 
because of the extensive genetic diversity between the two genotypes of PRRSV it would 
be difficult to make meaningful corresponding mutations unless they occur in a highly 
conserved region. 
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COMPARISON OF PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS (PRRSV) GROWTH IN FETAL BOVINE SERUM AND A 
SERUM REPLACEMENT SUPPLEMENTED MEDU 
A paper submitted to the Journal of Veterinary Diagnostic Investigation 
Susan K. Schommer, Susan L. Carpenter, Prem S. Paul 
Short CommunicatioD 
Porcine reproductive and respiratory syndrome virus (PRRSV) was first isolated in 
Europe on primary porcine alveolar macrophages (PAM) and designated Lelystad virus.' 
The U.S. PRRSV isolate was isolated on a continuous cell line ATCC CL2621^ In 
addition to PAM cultures' and the CL2621 cell line\ the MARC 145^ and ATCC 
CRLl 1171^ cell lines have also been shown to support PRRSV replication. Both US and 
European PRRSV isolates replicate well in PAM cultures, but difficulties and expense in 
obtaining these cells limit their use. Therefore, a continuous cell line is most often used to 
isolate and propagate PRRSV. 
Virus isolation is a commonly used method for the detection of PRRSV infection in 
many diagnostic laboratones. Clinical and diagnostic laboratories that maintain cell 
cultures for virus isolation can be affected by the cost and availability of fetal bovine serum 
(FBS).^ FBS carries the risk of contamination with bovine viruses, batch-to-batch variation, 
and increased expense making a serum replacement desirable, particularly in clinical and 
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diagnostic settings. Commercially available serum replacements are often used as a 
substitute forFBS. 
Previous studies of serum replacements have shown variable results in their ability 
to support the growth of cell cultures and to replicate virus. This indicates that the 
adaptability of cell lines and their capability to propagate virus must be examined on an 
individual cell line basis. The variation in PRRSV propagation on various cell types has 
been reported, but differences due to media or media supplement changes have not been 
reported.'"' This study compares the growth of PRRSV isolates in CRLl 1171 cell cultures 
maintained in either F6S or a serum replacement". 
In order to compare the replication of PRRSV in both media supplements, 
CRLl 1171 cells were split into two populations, one maintained in Dulbecco's modified 
Eagle media (DMEM) containing 10% FBS and the other in DMEM supplemented with 
10% serum replacement. After 3 passages in the respective supplemented media, confluent 
monolayers of both cell populations were grown on 12-well plates. The cells showed no 
difference in growth rates or morphology regardless of the serum supplement used (data not 
shown). The CRLl 1171 monolayers were infected in triplicate with passage 11 VR-2385, 
a well-characterized virulent US PRRSV isolate, at 0.05 and 0.005 moi."*'^  After 1 hour 
adsorption, the inoculum was removed and replaced with DMEM plus 2% of the 
appropriate serum. At 24,48,72,96, and 120 hours post-infection, triplicate wells grown 
in each serum and at each moi were harvested by scraping and the cell/supematant mixture 
was frozen overnight at -80 ®C. The virus stocks were thawed and clarified by 
centrifiigation at 1100 x g for 10 minutes. The virus was then serially diluted at 10-fold 
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dilutions and 100^1 was used to infect monolayers of cells on 96-weU plates in 
quadruplicate. After 1 hour adsorption, 100^1 of DMEM plus 2% FBS was added to each 
well and the plates were incubated for 48 hours. Fiffy percent tissue culture infectivity dose 
(TCID50) was then determined by IFA using a monoclonal antibody, 67efi which 
recognizes the nucleocapsid protein.^" The growth curves were then repeated using the 
same virus stock. 
PRRS virus isolate VR-2385 replicated to a higher titer in cells supplemented with 
FBS, as compared to the cells grown in the serum replacement The maximum titer of 
virus grown in serum replacement was 1.5-2 logio lower than that of the FBS grown virus. 
Figure 1 shows that VR-2385 consistently grows to at least 1 logio higher titer in FBS than 
in serum replacement from 24-120 hours post-infection. Using a standard t-test, the 
difference in viral titer of VR-2385 grown in FBS-supplemented media was statistically 
significant (P < 0.05) at all timepoints and at each moi. This demonstrates that an 
increased viral titer in FBS-supplemented media is not time dependent The difference in 
the VR-2385 titer in the two growth conditions is a little larger at most timepoints with the 
lower moi of0.005, with an average 99.3% reduction in titer, as compared to a 97.8% 
reduction at an moi of 0.05 (Table 1). This suggests that the growth of PRRS virus in 
serum replacement-supplemented cells may be more affected by adverse growing 
conditions, such as low numbers of infectious virus. 
To confirm that the differences in PRRS viral growth rate were not unique for 
isolate VR-2385, another isolate, ISU-79, was then used to infect CRLl 1171 cells at 0.05 
moi. ISU-79 had approximately a 1.5 logio higher titer when grown in FBS-supplemented 
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cells than in serum replacement-supplemented cells at all S timepoints (Figure 2). This 
demonstrates that the difference in serum used in cell propagation has an effect on the 
growth of more than one US PRRSV isolate. 
PRRSV is conunonly propagated on continuous cell lines. Clinical and diagnostic 
laboratories may use serum replacements in the maintenance of these cell lines in order to 
decrease costs and variability in the cultures. The adaptability of cell lines and viruses to 
commercial serum replacements has been variable and must be examined on an individual 
basis. In this study, we looked at the growth of two PRRSV isolates in the CRLl 1171 cell 
line maintained in 2 different media supplements, F6S and serum replacement. The results 
of this study show that PRRSV titers were consistently higher when the virus was 
propagated in cells grown in FBS as compared to cells grown in a serum replacement. The 
enhancement of viral propagation seen in FBS may be greater at lower multiplicites of 
infection, as would commonly be seen in virus isolations for diagnosis of field cases. This 
increase in viral titers in FBS supplemented media, as compared to those supplemented 
with serum replacement, was not time dependent and was consistent for two isolates. The 
observations made in this study suggest that the use of serum supplement in PRRSV 
propagation can influence viral titers, which may have implications for PRRSV diagnosis 
by virus isolation. 
Sources and manufacturers 
a. JRH Biosciences, Lenexa, KS. 
b. Produced in our lab 
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Figure 1. Growth curve of VR-2385 passage 11 inCRL 11171 cells 
supplemented with either FBS or serum replacement The titer of 
VR-2385 is at least llogio TCIDso/ml higher at each timepoint when 
the virus is grown in FBS-supplemented cells. A. VR-2385 at .05 moi. 
B. VR-2385 at .005 moi. 
50 
Table 1. Relative logio titer of PRRSV VR-2385 in serum replacement (SR) versus fetal 
bovine serum (FBS) supplemented media at various multiplicities of infection 
Hours TCIDso/ml TCIDso/ml % TCIDso/ml TCIDso/ml % 
Post-
Infection 
in FBS at 
.05 moi 
in SR at 
.05 moi 
Reduction 
in titer at 
.05 moi 
in FBS at 
.005 moi 
inSRat 
.005 moi 
Reduction 
in titer at 
.005 moi 
24 4.46 3.13 97.1 3.92 2.42 99.2 
48 5.42 4.00 95.2 5.08 3.21 99.0 
72 5.58 3.83 97.7 5.67 3.50 99.2 
96 5.46 3.04 99.7 5.75 3.92 99.8 
120 4.67 2.83 99.3 5.96 3.71 99.1 
Average 97.8 99.3 
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Figure 2. Growth curve of ISU-79 in CRL 11171 cells supplemented with either 
FBS or serum replacement. At 24 hours post-infection, the titer of ISU-79 was 
below the detectable level of 1.75 logio TCZDjo/ml, with no positive wells at 10*' 
dilution. The titer of ISU-79 is about 1.5 logio TCIDso/ml higher at each timepoint 
when the virus is grown in FBS supplemented cells. 
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PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
GENOME CHANGES DURING CELL CULTURE ATTENUATION 
A paper to be submitted to the journal Archives of Virology 
Susan Schommer, Igor Morozov, Xiang-Jin Meng, Susan Carpenter, Prem Paul 
Abstract 
The genome of a cell culture-attenuated strain was analyzed and compared it to its 
highly virulent parent strain, VR-2385. The overall genome sequence difTered by less than 
1%, despite a significant change in virulence between the two strains. The vast majority of 
the nucleotide changes resulted in amino acid changes, with a 3:1 ratio of nonsynonymous 
to synonymous changes in the structural genes. Many of the amino acid changes in VR-
2385 p85 resulted in the high passage virus acquiring an amino acid that is the same as the 
other U. S. PRRSV isolates at that position. The sequence of VR-2385 p7 has many amino 
acid positions that are unique to that isolate, which may contribute to the high virulence of 
this isolate relative to other PRRSV isolates and should be considered as potential virulence 
determinants. 
Introduction 
Porcine reproductive and respiratory syndrome (PRRS) was first recognized in the 
United States in 1987 and has since been reported throughout much of Western Europe and 
Asia [Hill, 1990 #5; Kefifaber, 1989 #10; Done, 1996 #24]. The disease syndrome caused 
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by the PRRS virus (PRRSV) can vary greatly in severity. These differences in virulence 
observed in both experimental and natural infections depend on a complex of factors 
associated with host susceptibility and virus strain differences. Differences in virulence 
among naturally occurring PRRSV have been well demonstrated in regard to respiratory 
tract illness [Halbur, 1996 #25; Halbur, 1995 #2] as well as in their effects on the 
reproductive tract [Mengeling, 1996 #31]. Genetic differences among isolates of varying 
pathogenicities have also been well established, but the regions of the viral genome which 
contribute to these differences in virulence are unknown [Meng, 1995 #148; Meng, 1996 
#153], 
This study compared a serially passaged attenuated PRRSV isolate to its virulent 
parent strain, VR-2385 [Schommer, 2000 #238], This paper compares the entire genome of 
both passages of VR-2385 to identify genetic regions which may play a role in PRRSV 
virulence. The results of this study contribute candidate sequences for further study with 
the cDNA infectious clone and provide the first full-length sequence comparison of a high 
and low virulence isolate from the same lineage. 
Materiab and Methods 
Virus and Celb 
VR-2385 was isolated from a 160-sow herd in southwest Iowa experiencing severe 
respiratory disease and high numbers of late-term abortions [Halbur, 1995 #2; Meng, 1996 
#1]. The isolate was plaque purified three times and propagated on ATCC CRLl 1171 cells 
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as previously described [Meng, 1996 #1]. This virus was then serially passaged 84 times in 
the CRLl 1171 cell line to produce the high passage vims isolate used in this study. 
RNA isolation and RT-PCR 
VR-2385 p84 was used to inoculate CRLl 1171 cells at approximately 0.01 moi. 
After 24 hours, the media was removed and total RNA was isolated by the guanidinium 
isothiocyanate method, using a conunercial kit (Stratagene). The total RNA was then used 
in RT-PCR reactions using primers that were designed based on the VR-2385 p7 sequence 
(Table I) [Meng. 1994 #42; Meng, 1995 #148; Morozov, 1995 #151; Morozov, #239]. 
ORFs 2-7 were amplified using random hexamers for cDNA synthesis (Invitrogen) and 
PGR was performed for 30 cycles with Taq polymerase (GibcoBRL) with conditions 
optimized for each primer pair. ORFs la and lb were amplified by RT-PCR using virus 
specific primers for both reverse transcription and second-strand DNA synthesis with a 
commercial kit (Promega). PCR products ranged in size from 0.4 -1.8 kb. At least 3 RT-
PCR reactions for each set of primers were pooled and purified using a Wizard prep 
colunm (Promega). Both strands of the pooled purified PCR products were then sequenced 
at the Iowa State University DNA Sequencing and Synthesis Facility on an Applied 
Biosystems Prism 377 DNA sequencer using the Applied Biosystems Prism BigDye 
terminator cycle sequencing kit. 
Sequence analysis 
The results of the automated sequencing reactions were assembled into a full length 
sequence and analyzed using Mac Vector (International Biotechnologies) and PROSITE. 
The complete sequence was then compared to the previously sequenced parent strain, VR-
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2385 p7, as well as to other PRRSV sequences available on GenBank (PRU87392, 
AF046869, M96262). 
Results/Discussion 
Genome analysis 
Overlapping RT-PCR products were directly sequenced and assembled into one 
contiguous sequence of 14,991 nucleotides. The genome of VR-2385 p7 was previously 
determined to consist of a major viral population of the same length, 14,991 nucleotides, 
and a minor population with a length of 15,100 nucleotides (nt) [Morozov, #239]. PRRSV 
strain VR-2385 p85 is 420 nt shorter than the previously reported U.S. isolates and is 97 nt 
shorter than Lelystad virus (LV) (Figures 1 and 2) [Allende, 1999 #165; Meulenberg, 1998 
#227; Nelsen, 1999 #33], The entire genome of the attenuated PRRSV VR-2385 p85 was 
then analyzed and compared to its virulent parent strain and found to dififer by about 0.6% 
at the nucleotide level (Table 2). Since the two passages of VR-2385 are from the same 
original isolate, the strain-to-strain variation normally seen among PRRSV isolates is 
eliminated, facilitating the search for genes important in virulence. 
5'NTR 
The 5' non-translated region of the PRRSV genome, also known as the leader 
sequence, is important in the formation of the nested set of subgenomic mRNAs [van 
Marie, 1999 #236; Sawicki, 1998 #154; van der Most, 1995 #155; Lai, 1989 #156; Baric, 
1985 #157]. Li VR-2385, the leader is 190 nucleotides long. Comparison to the other 
available U.S. PRRSV sequences demonstrated that the leader is highly conserved among 
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U.S. isolates, with 98% or greater nucleotide identity. The leader sequences of U.S 
PRRSV isolates are distinct from the European sequence, although there are regions of 
significant homology at the 3' end of the leader sequence which is believed to be critical 
for its binding to leader-body junction sites within the genome and at the 5'end 
[Oleksiewicz, 1999 #228; Nelsen, 1999 #33]. The only change between strains VR-2385 
p85 and p7 in the leader sequence is in the middle, with an adenine to guanine substitution 
at position 55 (data not shown). Interestingly, the same nucleotide change occurred 
between the two European leader sequences that have been reported, LV and 111/92 
[Oleksiewicz, 1999 #228; Meulenberg, 1993 #44]. This high degree of conservation 
between the attenuated and virulent VR-2385, is similar to the level of nucleotide identity 
between VR-2332 and the vaccine strain, and may indicate that the 5' untranslated region is 
not involved in attenuation [Oleksiewicz, 1999 #228]. 
ORFla analysis 
The ORFla of VR-2385 p85 encodes 2358 amino acids, which is 145 residues 
shorter than the other U.S. PRRSV isolates and 38 amino acids shorter than LV. This was 
due to an internal deletion in nonstructural protein 2 (nsp2). Nsp2 is the most variable 
region among arteriviruses and has been speculated to be involved in species-specific 
functions [de Vries, 1997 #164; Allende, 1999 #165]. However, even among the North 
American and European PRRSV genotypes, which both are restricted to pigs, there is only 
32% homology [Allende, 1999 #165]. 
There are six non-structural proteins that are predicted to result after ORFla 
polyprotein cleavage, with nspl being further cleaved into nspla and nspip [de Vries, 
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1997 #164], PRRSV VR-2385 p85 had 27 amino acid changes in OBUFla, evenly 
distnbuted at a rate of about 1% amino acid identity change in each of the individual 
proteins. Within nspl-3, however, the amino acid changes tended to be clustered. All of 
the predicted catalytic sites and cleavage sites were conserved in all of the U.S. isolates 
[Allende, 1999 #165], 
Nsp2 is the most variable protein in the replicase region and was the protein that 
contained the deletion. The parent strain, VR-2385 p7, had been shown previously to 
contain two different deletion species in ORFla, a major subpopulation that has the same 
deletion as the p85 strain, and an independent minor deletion that was lost during cell 
culture passage [Morozov, #239]. Sequence alignment of all available PRRSV sequences 
(Figure 2), showed that p85 and p7 VR-2385 were 97% identical and that these strains had 
88% amino acid identity with PRRSV strains 16244B and VR-2332. There is less 
homology between VR-2385 strains and VR-2332 and 16244b in this protein than in the 
other replicase proteins, with most of the amino acid changes occurring in the area of the 
deletion. Despite low homology with LV, the deletion region identified in the VR-2385 
strains overlapped with 76 amino acids that were deleted in LV. This may indicate that this 
region of ORF la is susceptible to and tolerant of deletions and insertions. 
ORFlb 
The polyprotein encoded by PRRSV ORF lb is believed to be cleaved by proteases 
from ORFla of the genome and to produce 4 viral proteins. This protein is highly 
conserved, with the available U.S. isolates all having 98-99% nucleotide identity. VR-
2385p7 and p85 have 99.5% nucleotide identity in ORF lb. The changes in the cell culture 
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attenuated VR-2385 p85 were confined to the 5' end where the RNA dependent RNA 
polymerase (RdRp) and cleavage protein 2 are located. All of the predicted cleavage sites 
were intact. 
ORFs 2-7 
The 3' end of the PRRSV genome codes for the structural proteins and this region 
of the genome has been sequenced for a large number of PRRSV isolates. These include 
another cell culture-attenuated PRRSV, the MLV vaccine RespPRRS, and its parent strain, 
VR-2332 [Madsen, 1998 #191]. Among isolates characterized thus far, die most variable 
ORFs in this region are ORFs 3 and 5. Similarly we also identified the greatest percentage 
of nucleotide changes in these two open reading frames. These changes will be 
characterized in more detail below. 
The proteins encoded in 0RFs2 and 4 are believed to be minor structural proteins of 
PRRSV and are referred to as glycoprotein 2 (GP2) and glycoprotein 4 (GP4) [Meulenberg, 
1996 #169; Meulenberg, 1995 #185]. The only notable difference between VR-2385 p7 
and p85 in these proteins is a 10 amino acid truncation of GP2 due to a single nucleotide 
substitution that resulted in a premature stop codon. The C-terminus of GP2 is 
hydrophobic and has been predicted to be a membrane anchor [Meulenberg, 1996 #169]. 
The tnmcation of this protein results in the loss of a portion of the hydrophobic tail, which 
may decrease the stability of this protein in the membrane, but the biologic relevance of 
this tnmcation is not known. 
0RF6 encodes the non-glycosylated membrane protein, M, which is the most 
conserved structural protein (Kapur, 1996 #29; Meng, 1994 #42]. This corresponds to our 
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results of 98.9% amino acid identity, >vith three amino acid changes, with all three changes 
occurring in the N-terminal 25 amino acids. The only amino acid changes in the 
RespPRRS MLV strain, as compared to its parent strain, were also at the N-terminus 
although these changes are not in the same position as any of the changes observed here. 
Two of the changes observed in the attenuated, high passage VR-2385 actually match those 
aoiino acids already seen in the other U. S. PRRSV isolates, suggesting that it is the highly 
virulent low passage VR-2385 that is unique. 
0RF7 encodes for the nucleocapsid, a 15 kDa highly basic protein that is 
predominant in the virion [Meulenberg, 1995 #185]. Antibody to this protein is abundant 
in convalescent pig sera and is suitable for diagnostic testing, but this antibody is not 
PRRSV-neutralizing [Meulenberg, 1995 #185; Denac, 1997 #187; Rodriquez, 1997 #188; 
Loemba, 1996 #186], All 3 changes between high and low passage VR-2385 in this region 
are non-synonymous. Two potential nuclear localization sequences have been identified in 
this protein and none of the changes occur in these regions [Rowland, 1999 #183]. 
QRF3 
The protein encoded by 0RF3 has been characterized as a highly glycosylated 
protein that may or may not be part of the PRRSV virion [Gonin, 1998 #173; Mardassi, 
1998 #174; Meulenberg, 1995 #185]. The 0RF3 protein of Lelystad virus has been 
demonstrated to be part of the structural virion, whereas the 0RF3 of two other 
arteriviruses, lactate-dehydrogenase virus and equine arteritis virus has not been 
characterized as a structural protein [Meulenberg, 1995 #185; Faaberg, 1997 #189; de 
Vries, 1992 #190]. GP3 does not have a typical class 1 membrane protein hydrophobic 
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anchor, but there is a putative N-terminal signal sequence that may indicate its ability to 
pass through the membrane [Drew, 1997 #229]. 
The ORF 3 protein had the greatest percentage of amino acid changes for both cell 
culture-attenuated PRRSV strains (Table 3 and Figure 3). This protein is predicted to play 
a role in cellular immunity Puran, 1997 #175], which may be especially important for 
clearing PRRSV infections since neutralizing antibody does not appear to play a significant 
role [Yoon, 1995 #133; Loemba, 1996 #186]. Recently there was a report of ORF 3 
deletion mutants, with deletions as large as 8 amino[01eksiewicz, 2000 #177]. These 
deletions were near the 3' end in the ORF 3/4 overlapping region and correspond to the 
region that is recognized by neutralizing antibody. These deletion mutants are 
outcompeting non-deleted viruses in the field in Europe, suggesting that they may be 
emerging as a result of immunological pressure [Oleksiewicz, 2000 #177]. None of the 
amino acid changes identified in VR-2385 p85 were at the 3' terminus. There is increasing 
evidence for the role of this protein in the host immune response to arteriviruses, but it is 
unknown if regions other than the 3' end play a role [Katz, 1995 #54; Duran, 1997 #175; 
Gonin, 1998 #173; Hedges, 1999 #240]. The host immune response may be an important 
contributor to PRRSV virulence, as this virus has been shown to induce apoptosis in vivo 
and in vitro, with many more cells undergoing apoptosis than are infected by virus 
[Sirinarumitr, 1998 #241][Sur, 1998 #242][Suarez, 1996 #180]. There are no differences 
in glycosylation sites between the VR-2385 p7 and p85 viruses, but there are additional 
potential enzymatic cleavage sites in the VR-2385 p85 strain. These cleavage sites could 
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a stu(fy comparing the MLV RespPRRS/Repro™ to its parent strain [47], This mutation is 
in a highly conserved region of GPS that is predicted to be exposed on the virion surface [2, 
18,27,47], While the same mutation is not present in this study, there is a mutation in the 
same region, at position 158 (Figure 3b). The high passage VR-2385 isolate has a serine 
substituted for a proline, which could affect the conformation of the membrane surface. 
This ectodomain may be involved in receptor binding, linkage to 0RF6 or virus 
neutralization. 
Overall, there are two main features of the changes in ORFs 2-7 in high passage 
VR-2385 that stand out First, the vast majority of the nucleotide changes result in amino 
acid changes (Table 3). This suggests that the virus was under selective pressure to change 
during cell culture passage. Second, nearly 50% of the amino acid changes in VR-2385 
p85 result in the high passage virus acquiring an amino acid that is the same at that position 
for the other U. S. PRRSV isolates. VR-2385 p7 has many amino acid positions that are 
unique to that isolate, which may contribute to the high virulence of this PRRSV isolate 
[13-15,27]. 
Overall genomic differences 
In this study, we have analyzed the genome of a cell culture attenuated strain and 
compared it to its highly virulent parent strain, VR-2385. The overall genome sequence 
differs by less than 1%, despite the drastic change in virulence [45]. By comparing these 
sequence changes to the ones reported in the attenuated vaccine strain, RespPRRS, we have 
identified several regions that should be looked at further as having a potential role in 
PRRSV virulence. In that stucfy, there were only 11 nucleotide changes in ORFs 2-7, 
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resulting in 7 amino acid changes [23] (Table 3). Cell culture-attenuation of VR-2385 after 
85 cell culture passages resulted in 28 amino acid changes as compared to the parent strain. 
A possible reason for having four times as many amino acid changes is that the parent 
isolates of the attenuated strains differ greatly in their virulence. The parent strain of 
RespPRRS, VR-2332, caused interstitial pneumonia, but did not cause gross lung lesions or 
clinical respiratory disease [4], while PRRSV isolate VR-2385 is commonly used as a 
challenge isolate because reproducible clinical respiratory disease develops in young pigs 
and gross lung lesions are often near 50% at 10-14 days post-infection [13,14]. 
Nsp2, is the most variable protein within arteriviruses as well as within the PRRSV 
genotypes [6]. The presence of two different deletions in this region in VR-2385 may 
account for the difference in virulence observed between the high and low passages strains 
or cell culture passage may have selected for the smaller genome. It was previously 
suggested that ORFla and lb may be responsible for the attenuation of VR-2332 into the 
vaccine vims RespPRRS, since there were so few changes in the ORF2-7 sequence [23]. 
Further investigation into the function of this gene is required and a comparison of the 
RespPRRS attenuated strain to VR-2332 may be useful in determining if nsp2 plays a role 
in virulence. 
ORFs 3 and 5 were also identified as having a potential role in virulence. These 
proteins have been identified as being important for the immune response to PRRSV 
infection [10,19,38-40]. GP3 and GP5 are both glycosylated, but this modification does 
not appear to contribute to the difference in virulence observed between the two passages 
ofVR-2385. 
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There were amino acid changes in virtually every protein when comparing the 
attenuated VR-238S to its parent strain, so we can not discount the possibility that virulence 
differences may be determined by other regions of the genome. This study provides 
identification of several regions that should be examined as having a potential role in 
PRRSV virulence. 
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Table 1: Summary of the primers used for VR-2385 p85 amplification and sequencing 
Oligonucleotide (5' -»3 ') Location 
+QACGTATAGGTGTTGGC 
-TGGAAAGATTGCAGAAAGCCAGC 
3-19 
357-379 
+CACTGCTTTACGGTCTCTC 
-CAAAGAACTGCGAAACAGTCCACACGG 
158-176 
1944-1970 
+CGGCTGGCTGAGGTGATGC 
-CAAATCTAGGGGCTCGTCC 
1847-1865 
3043-3061 
+GGCGACAATGTTCCTAACAGTTGGGA 
-GAAAACAGGGAGATGGGAGACGAGG 
2750-2775 
3460-3484 
+GGTATTGCTCCCCTCTTGG 
-TGGTGGAGTAGCCAGACCG 
3590-3607 
4397-4415 
+CCAAAAGTGGTCAAGGTTTCCGC 
-TCAAGAAAAACACCAACCATAGG 
4280-4302 
4915-4937 
+TCCCAGCATGCCCTTACCCTGCCCT 
-CCACATTACAAAACTGGCCTGAGGGG 
4676-4700 
5623-5648 
+GGATTCGCCTTCTGCTTCACCGC 
-TCACAACCATCATCCGAGGCAGG 
5504-5526 
6142-6164 
+TGCTATCCTGGCTCACTCC 
-GGACGCAGAAACAAAGCAC 
5955-5973 
6471-6489 
+TCCTGCGGAATGAATCATGAGTC 
-GGGGTTTTGTAAGGTATGTCTCC 
6335-6357 
7750-7772 
+CCTGAGCGGGTAAAAGGAG 
-GGTTGTCTTCTTTGGTCCGTCTG 
7711-7729 
8866-8889 
+ATCTATGCACAGCAGATGG 
-CCTGACCAACCGTGCATTC 
8659-8677 
10,411-10, 429 
+CCCCAAGGTCGCACACAAC 
-ATAATGATATCAACAATGGACACCAAGAAC 
10,527-10, 
11,721-11, 
545 
750 
+GGTGAATTCGTTrTATTTCCCTCCGGGC 
-GGGGGATCCTGTTGGTAATAG/AGTCTG 
11,580-11, 
12,772-12, 
606 
797 
+GGGGATTCGGGATAGGGAATGTG 
-GGGGATCCTTTTGTGGAGCCGT 
12,649-12672 
13,992-14013 
+CAACTTGACGCTATGTGAGC 
-CGGCCGTGTGGTTCTCGCCAAT 
13,496-13,516 
14,965-14,986 
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Table 2: Summaiy of the genetic differences between VR-2385 p7 and p85 
Genetic region Nucleotide Nucleotide Amino acid Amino acid 
changes length changes length 
Genome 84 14991 NA NA 
Leader I 190 NA NA 
ORFla 38 7074 It 2358 
ORF lb 19 4392 7 1463 
0RF2 6 738 3* 246 
ORF 3 11 762 9 254 
ORF 4 4 534 4 178 
ORF 5 6 600 5 200 
ORF 6 4 522 2 174 
ORF 7 3 369 3 123 
3'UTR 0 151 NA NA 
= based on comparison with the same deletion in both passages of VR-238S 
" = single nucleotide change results in premature stop, counted as 1 AA change, but 
results in a 10 AA truncation 
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Table 3: Synonymous versus nonsynonymous amino acid changes in cell culture attenuated 
PRRSV isolates 
Virus Isolate 
VR-2385 VR-2332* 
ORF Synonymous Nonsynonymous Synonymous Nonsynonymous 
2 3 3 1 0 
3 3 9 1 3 
4 0 4 1 0 
5 1 5 0 2 
6 1 3 1 2 
7 0 3 0 0 
Total 8 27 4 7 
* - Based on information from Madsen, et al. [23] 
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Figure 1. Dot Nfetrix Plots of the genomes of selected PRRSV isolates. U. S. isolates 
analyzed at 95% stringency (A and B). VR-2385 p85 and LV analyzed at 65% stringency 
(C). 
75 
50 
VR-2385p85 AGKRARKARS CATATVAGRA. LSVRETRQAK GHEVAGANKA EHLKHYSPPA 
VR-2385p7m 
VR-2332 E 
16244B E D 
Lelystad AK.A AKS .KDS.P TPK..LPVPT CGITT T 
100 
VR-2385p85 EGNCGWHCIS AIANRMVNSK FETTLPERVR PPDDWATDED LVNAIRILRL 
VR-2385p7ni Q 
VR-2332 Q 
Nebraska I D. .A...Q.... 
Lelystad D.S VLA ..M. ..I.GD .TSP.TQYN. .E S.Y. ..Q..QC... 
150 
VR-2385p85 PAALDRNGAC VSAKYVLKLE GEHWTVTVTP GMSPSLLPLE CVQGCCEHKGG 
VR-2385p7m 
VR-2332 T G 
16244B T 
Lelystad ..TW. ,R,. PN...LI,.N .V..E.E.RS ..A.RS.SR. ..V.V.S-E.C 
200 
VR-2385p85 LGSPDAVEVF GFDPACLDRL AEVMHLPSSA IPAALAEMSG DSDRSASPVT 
VR-2385p7m V 
VR-2332 S 
16422B I..S W 
Lelystad VAP.—YPAD .LPKRA.EA. .SAYR.. .DC VSSGI.DFLA NP .PQ 
250 
VR-2385p85 TVWTVSQFFA RHNGGNHPDQ ARLGKIISLC QVIEDCCCSQ AAKIDNKTNR 
VR-2385p7m 
VR-2332 S V 
16422B S V 
Lelystad EF..LD.MLT SPS .ER SGFSSLYK.L LEWPQK.GA TEGAFIYAV. 
300 
VR-2385p85 VTPEEVLYLR GATNLEECLA RLEKARPPRV MDTSFDWDW LPGVEAATQT 
VR-2385p7m 
VR-2332 I 
16422B I 
Lelystad RML.DCPSSK Q.MA.LAKIK VPSSKA.SVS L.EC.PT..L AD-F,P.S.-
350 
VR-2385p85 TELPRVNQCR ALVPWTQKS LDNNSVPLTA FSLSNYYYRA QGDEIRHRDR 
VR-2385p7m 
23 3 2 X£C • • Q ••••• •••«•••••• •••••••••• •• • ••••• •••• • • • E • 
16422B NK. .Q A V. ..E. 
Lelystad -.R..SSGAA WLCSPDA.E FEEAAPEEVQ E.GHKAVHS. LLA.GPNNEQ 
Figure 2. Amino acid comparison of Nsp2 among all the PRRSV sequences available. 
Dots (.) represent sites of amino acid identity, dashes (-) represent areas of deletions. VR-
2385 pTMrepresents the major deletion species detected, VR-238S p7m represents the 
minor deletion species detected. 
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VR-2385p85 LNAVLSKLEG AVREEYGLMP TGPGPRPALP SGLDVLKDQM EEDLLELANA 
VR-2385p7m S G K 
VR**2332 •E*a**aT** RaaaEa**** 
16244B .T EV E T..R...E R 
Lelystad VQV.AGEQLK LGGCGLAVGN AHE.—ALVS A. .IN.VGGN LSPSDPMKEN 
400 
450 
VR-2385p85 QTTSEMMAWA AEQVDLEAWV KSYPRWTPPP PPPRVQPRKA KPVRSLPESK 
VR-2385p7m 
VR'"2332 KT•• •••K*a**R. 
152448 .A. .D V  KT.. .N K T ...K R. 
Lelystad MLN.REDEPL DLSQPAP.ST TTLV.EQT.D N.GSDAGALP VT..EFVPTG 
VR-2385p85 PVPAPRRKVR SDCGSPVLLG DNVPNSWEDL TVGGPLDLLT PPESVTPPSE 
VR-2385p7m R 
VR-2385p7M 
VR~2332 .........G .......S.. GO... 
16244B G P S.. GD... 
Lelystad .ILCHVEHCG TES.D S-S PL 
Lelystad ATASD-. GW.HGRR 
500 
A . S S . F . , P .  ...PA..S.. 
A.SS....P. ...PA.LS.. 
SDAQT..QPL NLSL.AW.VR 
550 
VR-2385p85 LALMSAPQHT FRPVTPLGEP APVPAPRRTV PRPVTSLNGP ILMSAPRHKF 
VR-2385p7m ...T S 
VR-2385p7M 
VR-2332 .VIV.S..CI ...A...S.. ..I G.. S P.SE. .PVP...R., 
16244B .VIV.S..CI ...A...S.. ..I G.. 5 P.SE. .PVP...R.. 
VF.K-..NAF .DGDSA.QFG E.SESSSVIE 
600 
VR-2385p85 QQVEKANLAT ATLTYQDEPL DLSASSQTE 
VR-2385p7m Y EAFPPAPLQN MGIPEVEGQE 
VR-2385p7M 
VR-2332 ...KRLSS.A .IPP Y EASPPAPPQS GGVLGVEGHE 
16244B ...KRLSS.A .VPLH.N Y EASPSAPPQS GGVLGVEGHE 
Lelystad DRTKD.PWD .PVDLTTSNE A. .WDPF.F AELKR-PRFS AQALIDRGGP 
650 
VR-2385p85 
VR-2385p7ia AEEVLSGISD ILDDINSAPV SSSGSLSSVA ITRPI 
VR-2385p7M 
VR-2332 AEETLSEISD MSGNIKPASV SSSSSLSSVR ITRPKYSAQA IIDSGGPCSG 
16244B AEETLSEISD MSGNIKPASV SSSSSLSSVE ITRPKYSAQA IIDSGGPCSG 
Lelystad LADVHAKIKN RVYEQCLQAC EPGSR 
700 
VR-2385p85 
VR-2385p7m 
VR-2385p7M 
VR-2332 HLQEViCETCL SVMREACDAT KLDDPATQEW LSRMWDRVDM LTWRNTSVYQ 
16244B HLQGVKETCL SVMREACDAT KLDDPATQEW LSRMWDRVDM LTWRNTSVCQ 
Lelystad ^ATPATREW LDKMWDRVDM KTWR 
Figure 2. (continued). 
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750 
VR-2385p85 CEFVMM PHTPAPSVGA ESDLTIGSYA 
VR-2385P7ni 
VR-2385p7M 
VR-2332 AICTLDGRLK FLPKMILETP PPYP 
16244B AIRTLDGRLK FLPKMILETP PPYP 
Lelystad .TSQF QAGRILA.LK FLP.MIDQ-T 
800 
VR-2385p85 TEDIPRILGK lEDAG—EMS NQGPSAFSEE K PVD DQPTKDPRMS 
VR-238Sp7m — L . 
VR-2385p7M 
VR-2332 ...V E. ..NV.--..A L D . LVN...I. 
16244B ...V E. . .NV. —. .A . .E.S D . LVN...I. 
Lelystad PPP...KNRA SDN..LKQLV A.WDRKL.VT PPP.PVG..L ..IVPPP-TD 
850 
VR-2385p8S SRRSDKSAPA RSAGTGGVGL FTDLPPSDGV DADGGGPLRT VKTKTERFFD 
VR-2385P7m 
VR-2332 .P.E.TS .P A. S A F. ...R.A. .L. 
X6244B ••••P«E* TA aPaaaaavA* SaaaaaSaaa AaaaaaaaFa aAaRaAaaLa 
Lelystad IQQE. VT P.D aPPH APaFaSRVST GGSWK.LMLS GRLAGSISQR 
900 
VR-2385p85 QLSRQVFNLV SHLPVFFSYL FKPGSGYSPG DWGFAALTLL CLFLCYSYPA 
VR-2385p7m F 
VR—2332 aaaaaaaaDa aaaaaaaaaR aaYaaGaaaa aaaaaaaFaa aaaaaaaaaa 
16244B D R aaH..Gaa.T F 
Lelystad MTW..EVFa. .aAaMLT.aS .RGSMA La.GWa.A. La.Ra.alL, 
950 
VR-2385p85 FGIAPLLGVF SGSSRRVRMG VFGCWLAFAV GLFKSVPDPV GTACEFDSPE 
VR-2385p7m 
VR-2332 P.S A 
16244B T P.S A 
Lelystad CL L....L. ...S.M F..STPSN.. aSS.DH 
987 
VR-2385p85 CRNILHSFEL LKPWDPVRSL WGPVGLGLA ILGRLLG 
VR-2385p7m 
VR-2332 
16244B L 
Lelystad .HAE.LAL.Q RQL.E.. .G S..LCV ...Ka.. 
Figure 2. (continued). 
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A. 
50 
VR-2385p85 MANSCTFLHI FLCCSFLYSF CCAWaDSNA TYCFWFPLVR GNFSFELTVN 
VR-2385p7 Y G 
LOO 
VR-2385p85 YTVCPPCLTR QAAAEAYEPG RSLWCRIGYD RCGEDDHDEL GFWPPGLSS 
VR-238Sp7 H S 
150 
VR-2385p85 EGHLTSVYAW LAFLSFSYTA QFHPEIFGIG NVSRVYVDIK HQFICAVHDG 
VR-2385p7 A S S 
200 
VR-2385p85 QNTTLPHHDN ISAVFQTYYQ HQVDGGNWFH LEWLRPFFSS WLVLNVSWFL 
VR-2385p7 L V 
254 
VR-2385p85 RRSPASHVSV RVFQTLRPTP PQRQAILSSK TSVALGIATR PLRRFAKSLS AARR 
VR-2385p7 S 
B. 
50 
VR-2385p85 MLGKCLTAGC CSQLLFLWCI VPSCFVALVS ANGNSSSNLQ LIYNLTLCEL 
VR-2385p7 G 
100 
VR-2385p85 NGTDWLANKF DWAVESFVIF PVLTHIVSYG ALTTSHFLDT VGLVTVSTAG 
VR-2385p7 C 
150 
VR-2385p85 FVHGRYVLSS lYAVCALAAL ICFVIRLAKN CMSWRYSCTR YTNFLLDTKG 
VR-2385p7 M 
200 
VR-2385p85 RLYRWRSSVI lEKRGKVEVE GHLIDLKRW LDGSAATPVT RVSAEQWGRP 
VR-2385p7 P S.. 
Figures. A. Amino acid compahsonofORFS protein (GP3) sequence for VR-238Sp8S 
and p7. B. Amino acid comparison of ORES protein (GPS) sequence for VR-238S p8S and 
p7. Dots (.) represent sites of amino acid identity. 
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BIOLOGICAL CHARACTERIZATION OF A CELL CULTURE-ATTENUATED 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) 
ISOLATE 
A paper to be submitted to the journal Virus Research 
Susan Schonuner, Patnck Halbur, Ryan Royer, Susan Carpenter, Prem Paul 
Abstract 
A highly virulent porcine reproductive and respiratory syndrome virus (PRRSV) 
isolate, VR-238S, was serially passaged 84 times in a continuous cell line to produce an 
attenuated strain. Naive pigs were inoculated with VR-2385LP (passage 8) or VR-2385HP 
(passage 85) to determine if cell culture passage resulted in decreased virulence as 
compared to the parent isolate. The pigs inoculated with VR-238SLP showed moderate 
clinical respiratory signs and had elevated temperatures S-11 days post-infection (DPI), 
whereas the pigs inoculated with VR-2385HP had only mild respiratory signs and no fever. 
Gross lung lesions, microscopic lung lesions, and microscopic lymph node lesions were all 
significantly (P $ 0.05) more severe in the VR-2385LP -inoculated pigs at 10 and 31 DPI. 
At 42 DPI, however, interstitial pneumonia was moderate in both inoculated groups. The 
results of virus isolation and titration from sera indicated that VR-2385LP-inoculated pigs 
had higher virus loads at early timepoints post-infection than did pigs infected with high 
passage virus. However in cell culture,VR-2385HP was able to replicate to a higher titer in 
both a continuous cell line and primary cells. Despite the differences in virulence and 
serum virus titers between the two strains of VR-2385, both passages of the virus were able 
to persist equally well. This model of high and low virulence PRRSV strains from the 
80 
same origmal field isolate was established to examine the biologic basis for strain 
differences in viral virulence, as well as to look for a biologic marker that could be used to 
distinguish virulent and avirulent PRRS V strains. 
L Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is economically one of the 
most important diseases facing the swine industry today. PRRS was first recognized in the 
United States in 1987 and has since been reported throughout much of Western Europe and 
Asia (Done et al., 1996; Hill, 1990; Keffaber, 1989). The disease syndrome caused by 
PRRS virus (PRRSV) varies greatly in severity. These differences in virulence observed in 
both experimental and natural infections depend on a complex of factors associated with 
host susceptibility and virus strain. Differences in virulence among naturally occurring 
PRRSV have been well demonstrated in regard to respiratory tract illness (Halbur et al., 
1995; Halbur et al., 1996) as well as in their effects on the reproductive tract (Halbur et al., 
1996; Halbur et al., 1995; Mengeling et al., 1996). 
To date there is no known biologlical marker of virulence, therefore virulence can 
only be determined by infecting naive pigs which is costly, time-consuming, and 
impractical. Genetic differences among isolates of varying pathogenicities have been well 
established, but the regions of the viral genome which contnbute to these differences in 
virulence are unknown (Halbur et al., 1996; Meng et al., 1995; Mengeling et al., 1996). 
One mecham'sm proposed to account for virulence differences is that more virulent isolates 
are better able to replicate in pigs (Mengeling et al., 1999a). This led to the hypothesis that 
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porcine alveolar macrophages (PAMs) would tend to select for virulent field strains in vitro 
(Mengeling et al., 1999a), but that hypothesis was not tested. Plaque size differences have 
also been suggested as a biological marker, but has not been demonstrated to be a predictor 
of virulence for other PRRSV isolates (Park et al., 1996). 
The restriction fragment length polymorphism (RFLP) test has become a well-
established method for typing PRRSV isolates (Wesley et al., 1998). This test is very 
effective at differentiating field strains from the RespPRRS/Repro^ (Boehringer 
Ingelheim) vaccine strain, but no specific digestion pattem or patterns have been identified 
as an indicator of virulence. Indeed, isolates of varying virulence often type with common 
RFLP patterns. As more pigs are exposed to the MLV vaccines, it becomes more and more 
likely that field strains will contain the "unique" restriction enzyme site found in the vacine 
(Wesley et al., 1999). Monoclonal antilxxly typing is under investigation as a virus typing 
method, but currently is not used to differentiate virulent from avirulent field strains 
(Benfieldetal., 1999; Yangetal., 1999). 
In this study, we compared a serially passaged PRRSV isolate, VR-2385HP, to its 
parent strain to determine if a highly virulent PRRSV strain could be attenuated by cell 
culture passage. The use of two strains fi:om the same genetic lineage decreases the genetic 
variation normally observed between PRRSV isolates. This model was established to 
examine the biologic basis for strain differences in viral virulence, as well as to identify a 
biologic marker that could be used to distinguish virulent and avirulent PRRSV field 
strains. 
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2. Materials and Methods 
2.1 Virus and Cells 
VR-2385 was isolated from a 160-sow herd in southwest Iowa experiencing severe 
respiratory disease and high numbers of late-term abortions (Halbur et al., 199S; Meng et 
al., 1996). The isolate was plaque purified three times and propagated on ATCC 
CRLl 1171 cells as previously described (Meng et al., 1996). This virus was then serially 
passaged 84 times in the CRLl 1171 cell line to produce the high passage virus isolate used 
in this study. In these experiments passage 84 and 85 are termed high passage isolates 
(VR-2385HP), whereas passages 12 and under were used as low passage isolates (VR-
2385LP). 
2.2 Experimental infection 
Forty-nine specific pathogen free (SPF) pigs were purchased at 13-17 days of age. 
The pigs were randomly divided into three separate animal isolation rooms, two rooms 
containing 18 pigs and the third containing 13 pigs. Virus inoculum was prepared by 
infecting confluent monolayers of ATCC CRLl 1171 cells with either p7 or p84 VR-2385, 
then freezing the fiasks at -70 'C when 50-70% cytopathic effect (CPE) was observed. 
Frozen material was thawed and clarified, titrated, and a final inoculation dose of 10^ fifty 
percent tissue culture infectivity dose (TCIDso) per 5 ml dose was used for challenge. Cell 
culture control inoculum consisted of cell culture media that was used to mock-infect CRL 
11171 cells and then processed identically to the virus fluids. Control inoculum was also 
admim'stered at 5 ml/ dose. After 48 hours of acclimation, 18 pigs were inoculated 
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intranasally with VR-238SLP, 18 pigs were inoculated intranasally with VR-238SHP, and 13 
pigs were administered the cell culture control inoculum intranasally. 
2.3 Clinical, pathological, and virological evaluation 
Rectal temperatures and clim'cal respiratory disease scores were recorded daily from 
0 days post-infection G^PI) to 14 DPI and then 3 times weekly until 28 DPI. The clinical 
respiratory disease score was assigned based on the degree of dyspnea or tachypnea 
observed for each pig on a scale of 0-6, where 0 = normal, 1= mild dyspnea and/or 
tachypnea when stressed, 2 = mild dyspnea and/or tachypnea at rest, 3 = moderate dyspnea 
and/or tachypnea when stressed, 4 moderate dyspnea and/or tachypnea at rest, S = severe 
dyspnea and/or tachypnea when stressed and 6 = severe dyspnea and/or tachypnea at rest, as 
described previously (Halbur et al., 1995). Clinical signs other than respiratory distress 
were recorded, but were not used to determine the respiratory score. 
Necropsies were performed on all pigs. Pigs were equally divided among each 
timepoint, with 6 from the VR-2385LP and VR-2385HP necropsied at 10,31 and 42 DPL 
The control group consisted of 4 pigs at 10 and 42 DPI, and S pigs at 31 DPI. Gross lung 
lesion scores were assigned as an estimate of the percent of the lung exhibiting grossly 
visible pneumonia, as described previously (Halbur et al., 1995). 
Sections were taken from all lungs, brain, heart, small intestine, spleen, tonsil, and 
lymph nodes for histopathologic examination. At the 10 and 31 DPI necropsies, lungs were 
inflated by infusion of 10% neutral buffered formalin in the trachea, then clamped and 
submerged in fixative. All tissues were fixed in 10% neutral buffered formalin for 1-5 days 
and routinely processed. 
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All tissue sections were blindly examined and any abnormal observations were 
noted. Lung sections were scored on a scale from 0-6, based on the severity of the 
interstitial pneumonia present; as 0 = no microscopic lesions, 1 = mild pneumonia, 2 - mild 
dif^use pneumonia, 3 = moderate multifocal pneumonia, 4 = moderate diffuse pneumom'a, 
S = severe multifocal pneumonia, and 6 = severe diffuse pneumonia (Halbur et al., 1995). 
Cranial sternal and medial iliac lymph node sections were scored 0-3, based on the size and 
number of follicles. A score of 0 - 4-8 normally defined follicles per low power field (Ipf), 
1 = 9-14 well-defined follicles per Ipf, 2 = 15-20 well-defined follicles per Ipf with some 
coalescing follicles evident, and 3 = 21 or more well defined follicles per Ipf and common 
coalescing of hypercellular and reactive follicles (Rotto et al., 1997). 
Virus isolation from serum was attempted by adding 0.1 ml of experimental pig 
serum to the cell maintenance media on a confluent monolayer of CRL 11171 cells in a 6-
well plate. The plates were incubated overnight at 37 **C and 5% CO2, then the media was 
removed and replaced with DMEM containing 2% FBS and 1% antibiotic/antimycotic 
(10,000 units/ml penicillin G, 10,000 m^ml streptomycin, 25 mg/ml amphotericin B). The 
plates were monitored daily for cytopathic effect (CPE) for up to 7 days, if no CPE was 
observed the cultures were frozen, thawed and blindly passed 2 additional times before 
being called negative. CPE positive wells were confirmed to contain PRRSV by IFA 
(Yoon et al., 1992). Four pigs were randomly selected from each of the 3 experimental 
groups and 10-fold serial dilutions of serum were used to determine the serum PRRSV titer 
at 10,28 and 35 DPL The dilutions were performed in quadruplicate and the titrations 
were repeated independently. 
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2.4 Virus growth curves 
Growth curves of VR-2385LP and VR-2385HP virus were conducted in both the 
continuous cell line, ATCC CRL 11171, and in primary cells, monocyte derived 
macrophages (MDNb). In both growth curves, a multiplicity of infection (moi) of 0.1 was 
used to infect 6-well plates. For the growth ciwe in CRL 11171 cells, 6-well plates were 
inoculated with 0.1 moi of either pi 1 or p84 VR-2385 virus and incubated at 37 "C for I 
hour. After 1 hour adsorption, the virus was removed and the plates were rinsed with fresh 
DMEM. New DMEM containing 2% FBS and 1% antibiotic/antimycotic was added to 
each well and incubated at 37 ^C. At each timepoint three wells were scraped, the cells and 
media were frozen at -70 "C overnight, clarified the next day, and returned to -70 °C. 
When all the timepoints had been completed, each was titrated using 10-fold serial 
dilutions in quadruplicate. The growth curve was repeated. 
For the growth curve in MDMs, blood was collected from 3 pigs and a density 
gradient was used to isolate peripheral blood monocytes (PBMCs) from each pig as 
previously described (Thackeret al., 1998). Each pig's MDNb were resuspended in RPMI-
1640 with 10% FBS and 1% antibiotic/antimycotic and evenly distributed on 6-well plates 
at a density of 8 x 10'^  per well. After 24 hours, nonadherent cells were removed and L929 
cultured fibroblast supernatant was added as previously descnbed (Genovesi et al., 1989; 
Thacker et al., 1998). Each well was infected with 0.1 moi of the appropriate virus passage 
and at each timepoint, 0.1 ml of supernatant was removed from 3 randomly selected wells 
for each pig and each passage of the virus isolate and stored at -70 "C until all timepoints 
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were collected. When all timepomts were completed, they were titrated on 96-well plates 
using 10-fold serial dilutions in quadruplicate to determine TCIDso. 
2.5 Assessment of Plaque Size 
Three-day-old monolayers of CRL 11171 cells in 6-weIl plates were infected in 
duplicate with 10-fold dilutions of VR-2385 pi I and p85. The virus was allowed to absorb 
for 1 hour at 37 "C, the virus was then removed and 3 ml of CM cellulose and Sea Plaque 
agar in 2X DMEM were added. The plates were incubated inverted at 37 "C for 3 days, 
after which an overlay of 2 ml of Sea Plaque agarose, 2X DMEM and neutral red was 
added and the plates were incubated for an additional 24 hours. At this time, 100 plaques 
per isolate passage were measured using a caliper. 
3.0 Results 
3.1 Clinical Disease 
In vitro passage of PRRSV isolate VR-2385 in cell culture significantly reduced the 
severity of clinical signs associated with PRRSV infection. The VR-2385LP -inoculated 
group had significantly (P < 0.05) more severe respiratory signs than both the control and 
VR-2385HP -inoculated groups by 2 DPI and continuing through 17 DPI (Figure 1). Clinical 
disease was most severe in the VR-2385U> group at 6 DPI, with a peak mean score of 2.5 on 
the 0-6 scale. Average daily rectal temperatures were also significantly elevated in the VR-
2385LP -inoculated group, as compared to the control and VR-2385HP -infected pigs from 5-
11 DPI (P^ 0.05). The VR-2385HP -inoculated pigs did not have an elevated temperature at 
any timepoint (data not shown), however, long-term cell culture passage did not completely 
87 
attenuate viral virulence. The VR>2385HP -inoculated pigs exhibited mild respiratory 
disease that did not appear until 4 DPI, but persisted as long as the clinical disease observed 
in VR-238SLP -inoculated pigs. Clinical respiratory disease scores were significantly (P  ^
0.05) higher in VR-2385HP -inoculated pigs than the controls from 4 -13 DPI, as well as at 
17 and 21 DPI. Control pigs remained normal throughout the study, while clinical 
respiratory disease was observed in both the VR-238SHP and VR-2385LP-inoculated groups. 
Therefore, cell culture passage significantly reduced the clinical disease caused by VR-
238SHP as compared to its parent strain, but the clinical signs of PRRSV were not 
completely eliminated in this group of animals. 
3.2 Gross and Microscopic Lesions 
Pigs were necropsied at 10,31 and 42 DPI, at which time gross lung lesions were 
evaluated and scored based on the percentage of the lung affected. As previously observed 
(Halbur et al., 1996; Halbur et al., 1995), the VR-2385LP -inoculated group had extensive 
pneumonia at 10 DPI, which decreased in severity at 31 DPI (Table 1). Surprisingly, there 
were still gross lung lesions present in this group at 42 DPI. The VR-2385HP -infected pigs 
had significantly (P^ 0.01) reduced gross lung lesion scores as compared to the pigs 
infected with VR-2385LP at all timepoints; however, the lesions were more severe (P< 0.05) 
than the control pigs at 10 and 31 DPI. By 42 DPI, lung lesions in the VR-2385HP -infected 
group had resolved and were no longer significantly different than the controls. A single 
pig in the control group had a gross lung lesion score of 1% at 31 DPI, no other control pigs 
had any gross lesions at any timepoint. 
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All tissues collected at necropsy were examined microscopically, with the 
predominant lesions consisting of interstitial pneumonia and lymph node hypertrophy and 
hyperplasia. Interstitial pneumonia scores were reflective of clinical disease and gross lung 
lesion scores at 10 and 31 DPI (Table 2). VR-238SLP -infected pigs had moderate 
multifocal pneumonia at all three necropsy timepoints (Figure 2). Unexpectedly, the VR-
2385HP -infected pigs had no microscopic lung lesions at 10 DPI; however, the animals 
showed significant interstitial pneumonia lesions at 42 DPI. Thus the VR-238SHP -infected 
pigs had delayed onset of microscopic lung lesions, but lesions persisted similar to the 
lesions in VR-2385LP -infected pigs. 
Lymphadenopathy was observed in both the VR-238SLP and VR-238SHP -infected 
groups at all three timepoints with lymph nodes enlarged 2-4 times that of pigs in the 
control group (data not shown). Histopathologically, the lymph nodes of VR-2385LP -
infected pigs had significantly (P^ 0.05) higher follicular definition scores at ail 3 
timepoints than the control and VR-2385HP -infected pigs (Figure 3). At no timepoint were 
the lymph nodes of the VR-2385HP -infected pigs more reactive than those of the control 
pigs. 
3.3 Virus Isolation and Titration 
Clinical respiratory disease signs and microscopic lung evaluation of VR-238SHP -
inoculated pigs indicated that these animals had a more mild form of PRRSV respiratory 
disease that was delayed in onset but persisted equally well as compared to the disease in 
VR-238SLP. In order to determine if these differences in disease course were associated 
with differences in the presence of virus, sera collected at sequential timepoints were 
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assayed for PRRSV (Figure 3). All of the pigs inoculated with VR-2385LP were viremic 
from 3 -21 DPI. At 28 and 35 DPI, 42% and 83% of the of VR-2385LP -inoculated pigs 
were viremic, respectively. By 42 DPI no virus could be detected in the serum of any pigs 
of this group. The number of viremic pigs in the VR-2385HP -inoculated group was more 
variable, ranging from 33-67% throughout the experiment, with 1 pig remaining positive at 
42 DPI. All of the control pigs remained negative throughout the study. 
To determine if there was any difference in virus titer in the pig sera, selected pig 
sera were titrated, and the results are summarized in Figure 4. At 10 DPI, the pigs infected 
with VR-2385LP had TCIDso/ml more virus in their serum than theVR-2385Hp -
infected pigs. At 28 and 35 DPI there was very little difference among the virus titers 
between the groups and from one timepoint to another. The results of virus isolation and 
titration from sera indicate that VR-2385LP replicated better in vivo at early timepoints post­
infection than the VR-2385HP virus. Although the high passage isolate did not reach as 
high a titer in the pigs, it was able to persist equally well as the virulent low passage virus. 
3.4 In vitro growth characteristics 
The in vivo studies demonstrated that the major pathological differences between 
high and low passage VR-2384 were associated with differences in viral replication early in 
infection. To determine if differing replication rates of the two passages of VR-2385 could 
be used asm in vitro marker for the changes in pathogenicity, growth curves were 
conducted in both cell line CRL 11171 and in MDMs, In both cell types, VR-2385HP 
replicated to a sigm'ficantly higher titer (p^O.Ol) than VR-2385LP. In the continuous cell 
line, the peak viral titer of VR-2385HP was reached at 10^^^ TCIDso/ml at 30 hours post-
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infection (PI), whereas isolate VR-2385LP peaked at 42 hours PI with a titer of 10^ 
TQDso/ml (Figure S). Since VR-2385 was attenuated by serial passage on this cell line, it 
was not surprising that VR-2385HP was able to reach a higher peak titer and to reach this 
peak more quickly. In the MDMs VR-238SHP replicated to a significantly (p^ 0.001) higher 
titer at all timepoints post-infection than the low passage virus, in contrast to the in vivo 
replication abilities of these strains (Figure 6). Overall, both viruses grew to higher titers in 
CRL 11171 cells than in MDMs, which was not surprising since VR-238S was isolated and 
plaque purified on CRL 11171 ceils. 
Cytopathogenicity, as measured by plaque size has been suggested as an in vitro 
virulence marker for PRRSV (Park et al., 1996). The plaque size detennined for VR-
238SHP was 1.57 ± 0.35 mm, while the plaque size of VR-2385LP was 1.48 ± 0.29 mm. 
The two passages of virus do not have significantly different plaque sizes, despite their 
significant differences in pathogenicity, indicating that this test may not be a good indicator 
of relative virulence among PRRSV isolates. 
4.0 Discussion 
Variation in PRRSV virulence due to differences between virus isolates has been 
well established (Halbur et al., 1996; Halbur et al., 1995; Meng et al., 1995; Mengeling et 
al., 1996). To date there are no known genetic or biologic markers of virulence for PRRSV 
isolates. In this study a highly virulent PRRSV isolate, VR-2385, was attenuated by cell 
culture passage to establish a model of high and low virulence strains from the same 
lineage. By using a high and low cell culture passage of the same isolate, reduces 
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background variablity facilitating the identification of m vitro genetic and biologic 
predictors of virulence. In this study, differences in clinical signs and pathological lesions 
in the animals were reflective of the serum virus titer differences observed in the VR-
2385LP and VR-2385HP -infected animals. 
At 10 and 31 DPI, clinical disease, gross lung lesion scores and interstitial 
pneumonia scores were consistent with moderate to severe disease for VR-2385LP -
inoculated pigs and with mild respiratory disease for VR-238SHP -infected pigs. Recent 
studies with a commercial MLV PRRS V vaccine demonstrated clinical and pathological 
observations similar to the cell culture-attenuated isolate used in this study 
(Thanawongnuwech, 2000). Surprisingly, at 42 DPI the VR-238Su> -inoculated pigs still 
had 10% of the lung grossly affected by interstitial pneumonia. At 42 DPI the VR-2385HP -
inoculated pigs had interstitial pneumonia scores that had become more severe and were no 
longer significantly different firom those of the pigs infected with VR-238Sui. This 
indicated that the onset of pneumonia was delayed, rather than eliminated in the VR-
2385HP -inoculated pigs. Most PRRSV pathogenicity studies have focused on the degree of 
lesions observed at peak clinical disease and have not observed the long-term effects of 
PRRSV infection. Based on the delayed onset of interstitial pneumom'a observed when 
infecting pigs with this cell-culture attenuated isolate, and the identification of both natural 
and experimental examples of PRRSV MLV reversion to virulence (Boetner et al., 1997; 
Mengeling et al., 1999b), further investigation in this area is needed. 
It was somewhat unusual that PRRSV-induced gross lesions remained 42 days after 
VR-2385LP infection. Dual infection studies with PRRSV and Mycoplasma 
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f^ opnetmoniae have demonstrated that PRRSV-induced pneumonia is significantly 
prolonged and increased in severity by the presence of M. hyopneumoniae (Thacker et al., 
1999). To rule out the possibility that these lesions were due to the presence of a 
concurrent A/, hyopneimoniae infection, ELISA was performed on all 42 DPI sera. ELISA 
results indicated the pigs in all three groups were negative for anti-M hyopneumoniae 
antilxxiies at the end of the experiment There also was no indication of M 
hyopneimoniae-\xid!act,d. microscopic lesions in any of the pigs. The possibility of a break 
in biosecurity was also investigated, by sequencing selected PRRSV isolates obtained from 
the 35 DPI serum virus isolation results. The sequencing results indicated that there were 
not other PRRSV isolates present, from either within the experiment or from neighboring 
rooms. In a previous study utilizing VR-2385, gross lesions of 43.6% remained at 28 DPI 
in one trial, while they were completely resolved at 28 DPI in another trial (Halbur et al., 
1996). It is also possible that the extended presence of gross lesions may be related to 
differences in host susceptibility (Halbur et al., 1998). 
It has been previously suggested that the virulence of a particular isolate may be 
closely related to its ability to replicate in pigs (Haynes et al., 1997; Mengeling et al., 
1999a). The increased viral load observed in VR-238SLP -infected pigs in this study, 
supports the theory that virus load early after infection may be associated with viral 
virulence. To investigate if in vitro growth characteristics could be used as an in vitro 
correlate of in vivo virulence, growth curves were performed in both a continuous cell line 
and primary cells. In vitro, the high passage VR-238S was able to replicate better even 
when the cell type used was pig macrophages, thus indicating that a decreased ability to 
93 
replicate in primary porcine MDNk, at least in vitro, does not correlate with the attenuation 
of this isolate. There has been some debate as to whether or not macrophages derived from 
peripheral blood are permissive to PRRSV infection (Duan et al., 1997; Thacker et al., 
1998). The technique used to isolate and infect MDMs in this study was previously 
demonstrated to produce numbers of VR-2385 infected cells equal to those of porcine 
alveolar macrophages (PAMs) infected with the same isolate, although viral titers were not 
determined (Thacker et al., 1998). An advantage to using MDMs over PAMs is the ability 
to use the same pigs for replicating and standardizing a test. Although it can not be ruled 
out that the in vitro growth results may be different if the growth curves were conducted in 
PAMs, pig-to-pig variation in PAM infectivity would make it difficult to develop a test that 
was dependent on detecting differences in viral titers. Therefore, the results of this study 
indicate that in vitro replication ability would not be a good predictor of virulence. 
Despite differences in viral load and virulence, both virus passages of VR-2385 
were equally able to establish persistent infections. This result correlates with previous 
findings that while the total numbers and distribution of PRRSV positive cells may differ 
among isolates of varying pathogenicities, several isolates including a vaccine strain, persist 
equally well (Halbur et al., 1995; Haynes et al., 1997; Mengeling et al., 1996). The ability 
of both high and low virulence isolates to persist has important implications for the use of 
modified live vaccines in herds, especially when taking into consideration that there is 
evidence for the evolution of different quasispecies during infection with VR-2332, a MLV 
parent strain (Rowland et al., 1999). Outbreaks of disease in endemically infected or 
vaccinated herds may be caused by changes in the viral population during persistence that 
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result in a mutation that results in clinical disease (Boetner et al., 1997; Mengeling et al., 
1999b). 
Isolate VR-238S has been well established as a model for reproduction of gross and 
microscopic lesions in the respiratory system as a result of PRRSV infection (Halbur et al., 
1996; Halbur et al., 1995; Thacker et al., 1999; Thanawongnuwech et al., 1998). The work 
in this paper demonstrates that attenuation of a highly virulent PRRSV isolate can be 
achieved by serial cell culture passage, thus providing a good model for identifying 
biological and genetic virulence determinants by allowing comparison of a virulent isolate 
and an attenuated strain from the same lineage. This model permits comparison of an 
attenuated strain and its parent isolate that differ in virulence to a greater extent than the 
MLV vaccine RespPRRS/Repro™ differs in virulence from its parent isolate, VR-2332 
(Benfield et al., 1992; Benfield et al., 1999). Although no in vitro correlates of in vivo 
virulence were identified in this study, potential genetic markers of virulence may be 
identified by comparing the genomes of VR-2385LP and VR-2385HP, which share greater 
than 99% nucleotide identity (Schommer et al., 2000). 
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Table 1: Mean (± SEM) gross tung lesion scores* at necropsy 
J2EI1 
Treatment group 10 31 42 
Cell culture control 0±0* 0.2 ±0.4* 0±0* 
HP(p85) 2.211.5" 5.014.6" 0±0" 
LP(p8) 45.7 ±13.4® 17.717.6" 10.8 ±2.5" 
* Estimate of the percentage of entire lung affected by pneumonia 
+ Days post-inoculation, when pigs were necropsied 
® Different superscripts represent statistically significant (P^ 0.05) 
differences within a column 
Table 2: Mean (± SEM) microscopic lung lesion scores* 
DPr 
Treatment group 10 31 42 
Cell culture control 0±0" 0±0' 1.0 ±0' 
VR-2385 p85 0±0' 0.5 ±0.5' 2.7 ±1.0" 
VR-2385 p8 3.5 ±1.2" 2.7 ±0.5" 3.3 ±0.5" 
* See methods for description of scoring system 
Days post-inoculation, when pigs were necropsied 
" Different superscripts represent statistically significant (P< 0.05) 
differences within a column 
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Table 3; Mean (± SEM) microscopic lymph node scores* 
DPr 
Treatment group 10 31 42 
Cell culture control 0±0* 0.5 ±0.5' 1.3 ±0.5' 
VR-2385 p85 0±0* 1.0 ±0.6' 1.8 ±0.8' 
VR-2385 p8 1.3 ±0.8" 2.2 ±0.4" 2.8 ±0.4" 
* See methods for description of scoring system 
Days post-inoculation, when pigs were necropsied 
** ^ Different superscripts represent statistically sigm'ficant (P< 0.05) 
differences within a column. 
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Figure 1. Average daily clinical respiratory score for each of the treatment 
groups based on the 0-6 scoring system as descnlied in the methods, 
a = significantly (P^ 0.05) different than controls, 
b = sigm'ficantly (P< 0.05) different fromVR-2385HP -infected group 
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Figure 2. A. Nficroscopicsectioaoflungfromacoatrolgrouppig. 
B. Microscopic section of lung from a pig infected 31 days previously vath 
PRRSV strain VR-238SHP. There is mild multifocal proliferative and 
lymphohistiocytic interstitial pneumom'a. C. Microscopic section of lung 
from a pig infected 31 days previously with PRRSV strain VR-2385LP. 
There is moderate diffuse proliferative and lymphohistiocytic interstitial 
pnuemom'a. 
102 
B \/R-2385LPHnliBCtBd pigs 
• \/R-238SHPHnliBCiBd pigs 
10 14 21 28 
Days post-infection 
Figure 3. Percentage of VR-2385LP and VR-2385HP -infected pigs that 
were PRRSV positive by virus isolation from serum. 
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Figure 4. Serum virus titers (logio TCIDso/ml) in VR-2385LP and 
VR-2385HP-infected pigs at selected timepoints post-infection. 
Each point represents the viral titer of an individual pig, based on 
the average of two independent titrations. The lowest detectable 
titer is 1.0 logio TCIDso/ml.. 
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Figure 5. Growth curve of pl2 and p85 VR-238S inoculated at 0.1 moi on a 
continuous cell line, ATCC CRLl 1171. VR-2385 p85 reaches a higher 
overall titer, 10'°* TCIDso/ml versus 10^ TCIDjo/ml for pl2, and 
reaches the peak titer 12 hours earlier. 
105 
- VR-2385HP 
VR-2385LP 
12 18 24 30 36 48 
Hours postHnfecticn 
Figure 6. Growth curve of pl2 and p85 VR-2385 inoculated at 0.1 moi on a 
primary cell line, monocyte derived macrophages (MDMs). The PRRSV 
strain VR-2385 p85 consistently grew 1 logio TCIDso/ml higher at all 
timepoints than the VR-2385 pl2 strain. 
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GENERAL CONCLUSIONS 
My colleagues and I have achieved our overall objective of establishing a model of 
high and low virulence PRRSV strains from the same original field isolate, thus decreasing 
the amount of genetic heterogeneity that is normally associated with different isolates of a 
RNA virus. Differences in virulence were demonstrated in vivo, by infecting young pigs and 
documenting the amount of clinical and pathological respiratory disease. Biological 
characterization was also done in cell culture, comparing replication ability and plaque 
formation. Cell culture adapted virus showed phenotypical change as hypothesized, with 
changes in virulence and in replication ability. The complete genome of both passages of 
PRRSV strain VR-2385 were compared after sequencing of VR-2385 passage 85 was 
completed and genotypic change at a rate of about 1% at the nucleotide level was observed. 
However, the direct relationship of genotypic changes to their corresponding phenotypic 
changes still need to be elucidated. 
In the first study, growth of PRRSV was optimized in our continuous cell line by 
determining if the use of an artificial serum replacement resulted in a similar virus 
replication rate in cell culture. It was discovered that the titers of two different PRRSV 
isolates were reduced by 1 logto TCIDso when the cells were cultured in media 
supplemented with the serum replacement instead of fetal bovine serum. This effect was 
observed to be even more severe when the titer of the viral inoculum was low, as would be 
found when isolating virus from diagnostic samples. 
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Genetic markers of virulence were searched for by sequencing the entire genome of 
p85 VR-238S and comparing it to the previously sequenced p7 VR-238S (Meng et al., 1994; 
Meng et al., 1995a; Meng et al., 1995b; Morozov et al., 1995). Overall, genetic differences 
were found to be less than 1% at the nucleotide level, with the polymerase being slightly 
more conserved than the 3' end of the genome. Most of the nucleotide changes resulted in 
nonsynonymous amino acid sequence, indicating that selection was taking place during cell 
culture passage. The nsp2 protein, encoded in ORFla was determined to have a 145 amino 
acid deletion in VR-2385 p85 as compared to the other two U.S. PRRSV isolates that have 
been sequenced in their entirety. The p7 VR-2385 strain had predominantly this deletion, 
but there was also a subpopulation that contained only a 103 amino acid deletion. The p85 
VR-2385 strain only contained the 145 amino acid deletion. The nsp2 protein as well as the 
0RF3 protein, GP3, were determined to be the most likely regions of genetic changes that 
result in differences in viral virulence. Only 2 proteins were 100% conserved at the amino 
acid level for the two passages of VR-2385, so it can not be ruled out that changes in other 
regions may also contribute a change in pathogenicity. 
Biologic characterization of the two passages of VR-2385 was completed. Pigs 
were inoculated with 10^ TClDjo/ml intranasally using either passage 8 VR-2385 or passage 
85 VR-2385. Cell culture passage is a common method for producing attenuated strains of 
viruses and our study resulted in the attenuation of p85 VR-2385. Clinically the pigs 
inoculated with p85 VR-2385 did not have an elevated temperature and showed only mild 
respiratory signs, consistent with a mild form of PRRS and comparable to other low 
virulence isolates and the RespPRRS/Repro vaccine (Halbur et al., 1996; 
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Tlianawongnuwech et al., 1998). Pigs inoculated with p8 VR-2385 had a significant 
temperature for 6 days and respiratory signs that were observed earlier and were 
significantly more severe than those in the p8S group. 
Virus replication was decreased in vivo for VR-2385 p85 as compared to the parent 
strain. This was demonstrated by both a decrease in serum viral titer and a decrease in 
viremia. In vitro, however, the VR-2385 p85 isolate grew to a higher titer. 
This study provides a good model of high and low pathogenicity isolates for 
determination of viral virulence markers. Complete genome sequencing provides 
identification of regions potentially important for these changes in pathogenicity. There is 
currently a cDNA infectious clone for LV, the European PRRSV isolate, but due to the low 
amount of homology between U. S. and European PRRSV, a U. S. infectious clone is 
needed to further study the effect of the genetic changes observed in our study. Further 
studies need to be done to determine the role each of the viral proteins plays in order to 
better understand viral repb'cation mechanisms and how they relate to virulence. Although 
there are several PRRSV vaccines available, in many cases they have contributed to the lack 
control over PRRSV spread rather than eliminating it. Research into the basic biology of 
the viral proteins and their role in inducing immunity as well as the pathologic effects of the 
virus is needed. 
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